As filed with the Securities and Exchange Commission on September 19, 2025. |
Registration No. 333- |
Delaware | 7372 | 47-3424780 |
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
John T. McKenna Rachel Proffitt Jon C. Avina Milson C. Yu Jean Park Cooley LLP 3175 Hanover Street Palo Alto, California 94304 (650) 843-5000 | Howard Baik General Counsel and Secretary Navan, Inc. 3045 Park Boulevard Palo Alto, California 94306 (888) 505-8747 | Ran D. Ben-Tzur Cynthia C. Hess Jennifer J. Hitchcock Aman D. Singh Fenwick & West LLP 801 California Street Mountain View, California 94041 (650) 988-8500 |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |
Non-accelerated filer | ☒ | Smaller reporting company | ☐ | |
Emerging growth company | ☒ |
Per Share | Total | ||
Initial public offering price .................................................................................................................................................................................. | $ | $ | |
Underwriting discount(1) ...................................................................................................................................................................................... | $ | $ | |
Proceeds, before expenses, to us .................................................................................................................................................................... | $ | $ | |
Proceeds, before expenses, to the selling stockholders ............................................................................................................................... | $ | $ |
Goldman Sachs & Co. LLC | Citigroup |
Jefferies | Mizuho | Morgan Stanley |
BNP PARIBAS | Citizens Capital Markets | Oppenheimer & Co. | MUFG | Needham & Company | BTIG |
Loop Capital Markets | Academy Securities | Rosenblatt |
Page | |
GLOSSARY OF TERMS ............................................................................................................................... | |
LETTER FROM OUR CO-FOUNDERS .................................................................................................... | |
PROSPECTUS SUMMARY ......................................................................................................................... | |
RISK FACTORS ............................................................................................................................................. | |
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS ............................................... | |
INDUSTRY AND MARKET DATA ............................................................................................................... | |
USE OF PROCEEDS .................................................................................................................................... | |
DIVIDEND POLICY ........................................................................................................................................ | |
CAPITALIZATION .......................................................................................................................................... | |
DILUTION ........................................................................................................................................................ | |
OF OPERATIONS ...................................................................................................................................... | |
BUSINESS ...................................................................................................................................................... | |
MANAGEMENT .............................................................................................................................................. | |
EXECUTIVE COMPENSATION .................................................................................................................. | |
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS ............................................ | |
PRINCIPAL AND SELLING STOCKHOLDERS ........................................................................................ | |
DESCRIPTION OF MATERIAL INDEBTEDNESS ................................................................................... | |
DESCRIPTION OF CAPITAL STOCK ........................................................................................................ | |
SHARES ELIGIBLE FOR FUTURE SALE ................................................................................................. | |
OUR CLASS A COMMON STOCK ......................................................................................................... | |
UNDERWRITING ........................................................................................................................................... | |
LEGAL MATTERS ......................................................................................................................................... | |
EXPERTS ........................................................................................................................................................ | |
CHANGES IN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM .................................. | |
WHERE YOU CAN FIND ADDITIONAL INFORMATION ........................................................................ | |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS ..................................................................... |
Active customer ................................. | A customer that has transacted on our platform six or more times in the 12 months preceding the measurement date and that has generated any form of usage-based revenue from a user’s booking on our platform during this period. A single company or organization with multiple divisions, segments, or subsidiaries is generally counted as a single customer, even though we may enter into agreements with multiple parties within that company or organization. |
Bleisure category .............................. | The category of the business travel market defined by personal travel booked around or in connection with business travel. |
Customer ............................................. | A company or organization that contracts with us to provide its dedicated users with access to our (i) Travel, Corporate Payments, and Expense Management offerings, and/or (ii) on-demand travel management offerings (including our Meetings and Events, VIP, and Bleisure offerings). |
Customer Satisfaction Score (or CSAT score) ................................... | A measure of customer satisfaction, collected through post- interaction surveys that we prepare and distribute asking users to rate their experience with Navan's service consultants on a 5-point scale. CSAT is calculated by dividing the total number of 4 and 5 scores by the total number of responses in the measurement period. Navan uses CSAT to evaluate the quality of our customer support. |
Gross booking volume (or GBV) ..... | The total amount paid for valid bookings on our platform, measured on a booked basis and inclusive of total price, taxes, and fees, and adjusted for cancellations and refunds. GBV includes bookings for hotels, flights, cars, and rail, as well as usage of our Meetings and Events, VIP, and Bleisure offerings. See the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Key Business Metrics” for more information. |
Global Distribution System (or GDS) ................................................ | A third-party network operated by global technology providers that aggregates and distributes travel inventory such as flights, hotels, car rentals, and black car providers from travel suppliers to travel agencies and booking platforms. |
Low-Cost Carriers (or LCCs) ........... | Airlines with no-frills models that are not accessed by traditional GDSs, requiring TMCs and travel platforms to establish direct connections. |
Managed category ............................ | The category of the business travel market defined by travel activity governed by a formally implemented travel program. These programs are typically administered by a customer through a TMC or a dedicated travel platform, and are characterized by negotiated supplier contracts, documented travel policies, and mandated booking channels. |
Navan Cognition ................................ | Our innovative proprietary AI framework that combines the precision and predictive power of machine learning, or ML, with the reasoning capabilities of large language models. On our platform, Navan Cognition leverages third-party large language models with our own proprietary, internally developed software to enable us to create, train, deploy, and supervise our specialized virtual agents that can handle many complex tasks previously requiring human intervention. See the section titled “Business–Our Solution–Navan Cognition: Our New Paradigm in AI-Powered Travel Management” for more information. |
Navan Connect .................................. | Our open API framework that enables customers to integrate their existing third-party corporate card programs into our Expense Management application. |
Net Promoter Score (or NPS) .......... | A standardized measure of consumer satisfaction and loyalty that can range from a low of negative 100 to a high of positive 100. To calculate NPS, Navan users receive a survey asking, “How likely are you to recommend Navan to a friend or colleague?” on a scale from 0 to 10. Respondents are segmented into three groups: Promoters (score of 9 or 10), Passives (score of 7 or 8) and Detractors (score of 6 or less). NPS is then calculated by subtracting the number of Detractors from the number of Promoters, then dividing that number by the total number of respondents, then multiplying by 100. NPS benchmarks can vary significantly by industry, but a score greater than zero represents a company that has more promoters than detractors. Our NPS is calculated by us on a third-party platform, and we believe the methodology employed is substantially consistent with how other businesses and industries typically calculate their NPS. Our methodology for calculating NPS reflects responses from our customers who choose to respond to the survey question. Accordingly, NPS gives no weight to customers who decline to answer the survey question. Our NPS disclosed in this prospectus was derived from a sample size of approximately 20,000 users per month. We use NPS to assess the willingness of customers to recommend our offerings to others and generally regard NPS as a proxy for measuring brand loyalty and satisfaction. To calculate NPS, we take an average over the measurement period. |
New Distribution Capability (or NDC) ................................................ | An International Air Transport Association technical standard that enables airlines to offer dynamically priced fares, ancillary products, and rich content (such as seat maps and branded fares) through application programming interfaces, or APIs, that bypass certain legacy limitations of GDS. |
Offerings ............................................. | The suite of integrated products and services available on our platform. These offerings currently consist of Travel, Corporate Payments, Expense Management, Meetings and Events, VIP, and Bleisure. These offerings are accessible through our platform and may be adopted individually or in combination by our customers. See the section titled “Business—Our Offerings” for more information. |
Payment volume ................................ | The aggregate dollar amount of spend through Navan issued cards, settled during a given period and net of any chargebacks, cancellations, or refunds. See the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Key Business Metrics” for more information. |
Product-led growth (or PLG) ........... | Our go-to-market strategy in which our platform and our suite of offerings serve as the primary drivers of customer acquisition, expansion, and retention. In our PLG model, customers typically discover, sign up for, and begin using our offerings through our website or application, often with limited involvement from a sales representative. |
Sales-led growth (or SLG) ............... | Our go-to-market strategy in which qualified sales professionals actively identify, engage, and support prospective customers through the evaluation and purchasing process. In our SLG model, sales representatives directly prospect, engage, and guide potential customers through a structured and consultative buying process. |
Supplier ............................................... | A third-party provider of travel inventory or distribution services, including commercial airlines, low-cost carriers, hotel operators, lodging aggregators, rail carriers, car rental companies, black car or ground transportation providers, and operators of GDSs. Suppliers contract with us to make their inventory available for booking by customers and users on our platform and may compensate us through commissions, incentives, or transactional fee arrangements. |
T&E ....................................................... | Travel and expense. |
Travel management company (or TMC) ................................................ | A travel agency or organization that provides businesses with managed travel services such as offline booking support, policy compliance, duty-of-care assistance, and supplier negotiations. TMCs may access travel content through GDSs, direct supplier connections, or other distribution mechanisms, and typically earn revenue from supplier commissions, client service fees, and ancillary charges. |
Travel Management offerings ......... | A category of offerings available through our platform that includes our Meetings and Events, VIP, and Bleisure offerings, in addition to our Travel offering. These additional offerings are designed to support more complex or personalized travel needs beyond standard business travel, such as executive itineraries, group travel coordination, and personal travel booked in connection with business trips. |
Unmanaged category ....................... | The category of the business travel market defined by business travel that is not subject to a formal travel program or mandated booking channel. In an unmanaged environment, individual employees or teams arrange travel independently, often using consumer channels. |
User ..................................................... | Any individual authorized by a customer to access and use our platform. Users may include business travelers, executive assistants, travel coordinators, finance, accounting, or human resources personnel, and travel and expense administrators. Depending on their role and permissions, users may book or modify travel itineraries, initiate or reconcile expenses, transact using our corporate card solutions, or configure and manage customer- specific travel, payment, or expense policies within the platform’s administrative modules. |
Class A common stock offered by us ......... | shares |
Class A common stock offered by the selling stockholders ................................... | shares |
Underwriters’ option to purchase additional shares of Class A common stock from us ............................................. | shares |
Class A common stock to be outstanding after this offering ......................................... | shares ( shares if the underwriters exercise their option to purchase additional shares in full) |
Class B common stock to be outstanding after this offering ......................................... | shares |
Total Class A common stock and Class B common stock to be outstanding after this offering .................................................. | shares |
Use of proceeds ............................................. | We estimate that the net proceeds from our sale of shares of our Class A common stock in this offering will be approximately $ , or approximately $ if the underwriters’ option to purchase additional shares is exercised in full, based upon the assumed initial public offering price of $ per share, which is the midpoint of the offering price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We primarily intend to use the net proceeds from this offering for working capital and other general corporate purposes. We intend to use approximately $ of the net proceeds from this offering to repay the outstanding term loans under and terminate our credit agreement with VCP Capital Markets, LLC, referred to as the Vista Facility, the terms of which are described further in the section titled “Description of Material Indebtedness.” We also intend to use approximately $ of the net proceeds to satisfy the anticipated tax withholding and remittance obligations related to the RSU Net Settlement (as defined below). Assuming (i) the fair market value of our Class A common stock at the time of settlement will be equal to the assumed initial public offering price per share of $ , the midpoint of the price range set forth on the cover page of this prospectus, and (ii) an assumed % tax withholding rate, we estimate that these tax withholding and remittance obligations on the RSU Net Settlement will be $ million in the aggregate. We may also use a portion of the proceeds for the acquisition of, or investment in, technologies, solutions, or businesses that complement our business. However, we do not have agreements or commitments for any acquisitions or investments outside the ordinary course of business at this time. See the section titled “Use of Proceeds” for additional information. We will not receive any proceeds from sales of shares of Class A common stock by the selling stockholders. |
Voting rights .................................................... | Following the completion of this offering, shares of our Class A common stock will be entitled to one vote per share. Shares of our Class B common stock will be entitled to 30 votes per share. Holders of our Class A common stock and Class B common stock will generally vote together as a single class, unless otherwise required by law or our amended and restated certificate of incorporation. Following the completion of this offering, each share of our Class B common stock will be convertible into one share of our Class A common stock at any time and will convert automatically upon certain transfers and upon the earlier of . Immediately following the completion of this offering, and assuming no exercise of the underwriters’ option to purchase additional shares, Ariel Cohen, our co- founder, chairperson of our board of directors, and Chief Executive Officer, and a member of our board of directors, will hold approximately % of the voting power of our outstanding capital stock, and Ilan Twig, our co-founder, Chief Technology Officer, and a member of our board of directors, will hold approximately % of the voting power of our outstanding capital stock, which voting power may increase over time upon the exercise or settlement and exchange of equity awards held by our co-founders pursuant to their Equity Exchange Rights (as defined below). If all currently outstanding stock options to purchase shares of our Class A common stock held by our co-founders were exercised and exchanged for an equal number of shares of Class B common stock pursuant to the Equity Exchange Rights, then immediately following the completion of this offering, Messrs. Cohen and Twig would hold approximately % and %, respectively, of the voting power of our outstanding capital stock. As a result, our co-founders may have significant influence over the outcome of matters submitted to our stockholders for approval, including the election of our directors and the approval of any change of control transaction. These risks are more fully described in the section titled “Risk Factors.” See the sections titled “Principal and Selling Stockholders” and “Description of Capital Stock” for additional information. |
Risk factors ..................................................... | See the section titled “Risk Factors” and other information included in this prospectus for a discussion of some of the factors you should consider before deciding to purchase shares of our Class A common stock. |
Proposed Nasdaq trading symbol ............... | “NAVN” |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Consolidated Statements of Operations Data: | (in thousands, except share and per share data) | ||||||
Revenue ............................................................. | $536,837 | $402,256 | $329,413 | $253,727 | |||
Cost of revenue(1) ............................................. | 169,815 | 162,622 | 92,583 | 82,545 | |||
Gross profit ....................................................... | 367,022 | 239,634 | 236,830 | 171,182 | |||
Operating expenses | |||||||
Research and development(1) .................... | 122,386 | 132,442 | 64,760 | 57,784 | |||
Sales and marketing(1) ................................ | 218,722 | 220,511 | 130,376 | 103,530 | |||
General and administrative(1) ..................... | 133,552 | 133,023 | 69,845 | 65,238 | |||
Total operating expenses ................................ | 474,660 | 485,976 | 264,981 | 226,552 | |||
Loss from operations ....................................... | (107,638) | (246,342) | (28,151) | (55,370) | |||
Interest expense .......................................... | (75,997) | (63,281) | (31,971) | (37,851) | |||
Other income (expense), net ..................... | (73) | 10,093 | 6,699 | 1,953 | |||
Loss on extinguishment of debt ................ | — | — | (20,528) | — | |||
Gain (loss) on fair value adjustments ....... | 12,200 | (26,594) | (17,886) | 3,020 | |||
Loss before income tax expense ................... | (171,508) | (326,124) | (91,837) | (88,248) | |||
Income tax expense ......................................... | 9,570 | 5,428 | 8,043 | 4,296 | |||
Net loss .............................................................. | $(181,078) | $(331,552) | $(99,880) | $(92,544) | |||
Net loss per share attributable to common stockholders, basic and diluted(2) .............. | $(4.00) | $(7.44) | $(2.15) | $(2.05) | |||
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted(2) ........................................ | 45,271,666 | 44,583,919 | 46,350,553 | 45,153,649 |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
Cost of revenue ................................................. | $4,577 | $4,751 | $1,902 | $1,842 | |||
Research and development ............................ | 30,408 | 27,039 | 14,371 | 13,619 | |||
Sales and marketing ......................................... | 17,077 | 15,872 | 7,738 | 7,614 | |||
General and administrative ............................. | 24,919 | 28,189 | 11,898 | 11,838 | |||
Total stock-based compensation expense, net of amounts capitalized .... | $76,981 | $75,851 | $35,909 | $34,913 | |||
Capitalized stock-based compensation ........ | 2,319 | 1,130 | 1,395 | 1,096 | |||
Total stock-based compensation cost ...... | $79,300 | $76,981 | $37,304 | $36,009 |
Year Ended January 31, 2025 | Six Months Ended July 31, 2025 | ||
(in thousands, except share and per share data) | |||
Numerator: | |||
Net loss attributable to common stockholders ................................................ | $ | $ | |
Pro forma adjustment to record stock-based compensation expense related to RSUs for which the time-based service and performance- based vesting conditions will be satisfied in connection with this offering ............................................................................................................... | |||
Pro forma adjustment to reclassify the fair value of the redeemable convertible preferred stock warrant liability ................................................. | |||
Pro forma adjustment to reclassify the embedded derivative liability in connection with the Note Conversion .......................................................... | |||
Pro forma net loss attributable to common stockholders .............................. | $ | $ | |
Denominator: | |||
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted ................ | |||
Pro forma adjustment to reflect the Capital Stock Conversion .................... | |||
Pro forma adjustment to reflect the RSU Net Settlement ............................. | |||
Pro forma adjustment to reflect the Note Conversion ................................... | |||
Pro forma adjustment to reflect the SAFE Conversion ................................. | |||
Weighted-average shares outstanding used to compute, pro forma, net loss per share attributable to common stockholders, basic and diluted . | |||
Pro forma net loss per share attributable to common stockholders, basic and diluted(1) .......................................................................................................... | $ | $ |
As of July 31, 2025 | ||||||
Actual | Pro Forma(1) | Pro Forma as Adjusted(2)(3) | ||||
Consolidated Balance Sheet Data: | (in thousands) | |||||
Cash and cash equivalents ....................................................... | $223,229 | $ | $ | |||
Restricted cash, current ............................................................ | 87,218 | |||||
Working capital(4) ....................................................................... | 469,644 | |||||
Total assets ................................................................................. | 1,134,391 | |||||
Long-term debt(5) ........................................................................ | 658,158 | |||||
Other non-current liabilities(6) .................................................... | 23,678 | |||||
Total liabilities .............................................................................. | 1,041,721 | |||||
Redeemable convertible preferred stock ................................ | 1,301,121 | |||||
Additional paid-in capital ........................................................... | 522,555 | |||||
Accumulated deficit ................................................................... | (1,716,993) | |||||
Total stockholders’ (deficit) equity ........................................... | (1,208,451) |
Year Ended January 31, | Six Months Ended July 31, | |||||
2025 | 2024 | 2025 | 2024 | |||
(in billions) | ||||||
Gross booking volume (GBV) .......................... | $6.6 | $5.0 | $4.1 | $3.1 | ||
Payment volume ................................................ | $3.7 | $2.7 | $2.0 | $1.8 |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(dollars in thousands) | |||||||
GAAP gross profit ............................................. | $367,022 | $239,634 | $236,830 | $171,182 | |||
Non-GAAP gross profit (1) ................................ | $371,855 | $249,229 | $239,025 | $173,152 | |||
GAAP gross margin ......................................... | 68 % | 60 % | 72% | 67% | |||
Non-GAAP gross margin(1) ............................. | 69 % | 62 % | 73% | 68% | |||
GAAP loss from operations ............................ | $(107,638) | $(246,342) | $(28,151) | $(55,370) | |||
Non-GAAP income (loss) from operations(1) | $(25,042) | $(174,753) | $11,076 | $(17,485) | |||
GAAP net loss ................................................... | $(181,078) | $(331,552) | $(99,880) | $(92,544) | |||
Non-GAAP net loss(1) ....................................... | $(96,387) | $(224,353) | $(14,775) | $(49,413) |
As of July 31, 2025 | |||||
Actual | Pro Forma | Pro Forma as Adjusted(1) | |||
(in thousands, except share and per share data) | |||||
Cash and cash equivalents .................................................................... | $223,229 | $ | $ | ||
Restricted cash, current ......................................................................... | 87,218 | ||||
Debt, current and long term ................................................................... | |||||
ABL Facility ......................................................................................... | 34,500 | $ | $ | ||
Vista Facility(2) ..................................................................................... | 117,100 | ||||
Warehouse Credit Facility ................................................................ | 148,174 | ||||
Convertible notes, net ....................................................................... | 195,163 | ||||
Simple agreements for future equity (SAFEs) ............................... | 163,000 | ||||
Total debt ....................................................................................... | 657,937 | ||||
Embedded derivative liability ................................................................. | 38,500 | ||||
Common stock warrant liability ............................................................. | 31,200 | ||||
Redeemable convertible preferred stock warrant liability ................. | 433 | ||||
Redeemable convertible preferred stock; $0.00000625 par value per share; 157,027,585 shares authorized, 146,360,207 shares issued and outstanding, actual; no shares authorized, issued, and outstanding, pro forma and pro forma as adjusted ................ | 1,301,121 | ||||
Stockholders’ (deficit) equity: ................................................................ | |||||
Preferred stock; $0.00000625 par value per share; no shares authorized, issued, and outstanding, actual; shares authorized, no shares issued and outstanding, pro forma and pro forma as adjusted ............................................................ | — | ||||
Common stock; $0.00000625 par value per share; 253,919,000 shares authorized, 46,331,272 shares issued and outstanding, actual; no shares authorized, issued and outstanding, pro forma and pro forma as adjusted ........................................................................................... | 1 | ||||
Class A common stock; $0.00000625 par value per share; no shares authorized, issued, and outstanding, actual; shares authorized, no shares issued and outstanding, pro forma; shares authorized, shares issued and outstanding, pro forma as adjusted ........................ | — | ||||
Class B common stock; $0.00000625 par value per share; no shares authorized, issued, and outstanding, actual; shares authorized, shares issued and outstanding, pro forma; shares authorized, shares issued and outstanding, pro forma as adjusted ...................................................................................... | — | ||||
Additional paid-in capital ................................................................... | 522,555 | ||||
Accumulated other comprehensive loss ........................................ | (14,014) | ||||
Accumulated deficit ............................................................................ | (1,716,993) | ||||
Total stockholders’ (deficit) equity .............................................. | (1,208,451) | ||||
Total capitalization .................................................................. | $820,740 | $ | $ |
Assumed initial public offering price per share................................................... | $ | ||
Historical net tangible book deficit per share as of July 31, 2025 ................... | $ | ||
Increase per share attributable to the pro forma adjustments described above ............................................................................................................... | |||
Pro forma net tangible book value per share as of July 31, 2025 before giving effect to this offering ........................................................................... | |||
Increase in pro forma net tangible book value per share attributable to new investors purchasing Class A common stock in this offering .......... | |||
Pro forma as adjusted net tangible book value per share immediately after this offering ............................................................................................. | |||
Dilution in pro forma as adjusted net tangible book value per share to new investors in this offering ...................................................................................... | $ |
Shares Purchased | Total Consideration | Average Price Per Share | |||||||
Number | Percent | Amount | Percent | ||||||
Existing stockholders ............ | % | $ | % | $ | |||||
New public investors ............. | |||||||||
Total ........................................ | % | $ | % |
Year Ended January 31, | Six Months Ended July 31, | ||||||||||
2025 | 2024 | % Growth | 2025 | 2024 | % Growth | ||||||
(dollars in billions) | |||||||||||
Gross booking volume (GBV) ............................ | $6.6 | $5.0 | 32% | $4.1 | $3.1 | 34% | |||||
Payment volume ............. | $3.7 | $2.7 | 35% | $2.0 | $1.8 | 10% |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
Revenue .............................................................. | $536,837 | $402,256 | $329,413 | $253,727 | |||
Cost of revenue .................................................. | 169,815 | 162,622 | 92,583 | 82,545 | |||
Gross profit .................................................... | 367,022 | 239,634 | 236,830 | 171,182 | |||
Operating expenses | |||||||
Research and development ........................ | 122,386 | 132,442 | 64,760 | 57,784 | |||
Sales and marketing ..................................... | 218,722 | 220,511 | 130,376 | 103,530 | |||
General and administrative ......................... | 133,552 | 133,023 | 69,845 | 65,238 | |||
Total operating expense ................................... | 474,660 | 485,976 | 264,981 | 226,552 | |||
Loss from operations ........................................ | (107,638) | (246,342) | (28,151) | (55,370) | |||
Interest expense ........................................... | (75,997) | (63,281) | (31,971) | (37,851) | |||
Other income (expense), net ...................... | (73) | 10,093 | 6,699 | 1,953 | |||
Loss on extinguishment of debt .................. | — | — | (20,528) | — | |||
Gain (loss) on fair value adjustments ........ | 12,200 | (26,594) | (17,886) | 3,020 | |||
Loss before income tax expense .................... | (171,508) | (326,124) | (91,837) | (88,248) | |||
Income tax expense .......................................... | 9,570 | 5,428 | 8,043 | 4,296 | |||
Net loss ............................................................... | $(181,078) | $(331,552) | $(99,880) | $(92,544) |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
Cost of revenue ................................................ | $4,577 | $4,751 | $1,902 | $1,842 | |||
Research and development ............................ | 30,408 | 27,039 | 14,371 | 13,619 | |||
Sales and marketing ........................................ | 17,077 | 15,872 | 7,738 | 7,614 | |||
General and administration ............................. | 24,919 | 28,189 | 11,898 | 11,838 | |||
Total stock-based compensation expense ......................................................... | $76,981 | $75,851 | $35,909 | $34,913 |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Revenue ............................................................. | 100% | 100% | 100% | 100% | |||
Cost of revenue ................................................ | 32 | 40 | 28 | 33 | |||
Gross profit ................................................... | 68 | 60 | 72 | 67 | |||
Operating expenses | |||||||
Research and development ....................... | 23 | 33 | 20 | 23 | |||
Sales and marketing ................................... | 41 | 55 | 40 | 41 | |||
General and administrative ........................ | 25 | 33 | 20 | 25 | |||
Total operating expense .................................. | 89 | 121 | 80 | 89 | |||
Loss from operations ....................................... | (21) | (61) | (8) | (22) | |||
Interest expense .......................................... | (14) | (16) | (10) | (15) | |||
Other income (expense), net ..................... | — | 3 | 2 | 1 | |||
Loss on extinguishment of debt ................ | — | — | (6) | — | |||
Gain (loss) on fair value adjustments ....... | 2 | (7) | (5) | 1 | |||
Loss before income tax expense ................... | (33) | (81) | (27) | (35) | |||
Income tax expense ......................................... | 2 | 1 | 2 | 2 | |||
Net loss .............................................................. | (35%) | (82%) | (29%) | (37%) |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Usage-based revenue ..................................... | $299,698 | $232,448 | $67,250 | 29% | |||
Subscription revenue ....................................... | $29,715 | $21,279 | $8,436 | 40% | |||
Total revenue .......................................... | $329,413 | $253,727 | $75,686 | 30% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Cost of revenue ................................................ | $92,583 | $82,545 | $10,038 | 12% | |||
Gross profit ........................................................ | $236,830 | $171,182 | $65,648 | 38% | |||
Gross margin ..................................................... | 72% | 67% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Research and development ............................ | $64,760 | $57,784 | $6,976 | 12% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Sales and marketing ........................................ | $130,376 | $103,530 | $26,846 | 26% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
General and administrative ............................. | $69,845 | $65,238 | $4,607 | 7% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Interest expense ............................................... | $(31,971) | $(37,851) | $5,880 | (16)% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Other income, net ............................................. | $6,699 | $1,953 | $4,746 | 243% |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Loss on extinguishment of debt ..................... | $(20,528) | $— | $(20,528) | NM |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Gain (loss) on fair value adjustments ............ | $(17,886) | $3,020 | $(20,906) | NM |
Six Months Ended July 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Income tax expense ......................................... | $8,043 | $4,296 | $3,747 | 87% |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Usage-based revenue ..................................... | $490,356 | $371,728 | $118,628 | 32% | |||
Subscription revenue ....................................... | $46,481 | $30,528 | $15,953 | 52% | |||
Total revenue .......................................... | $536,837 | $402,256 | $134,581 | 33% |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Cost of revenue ................................................ | $169,815 | $162,622 | $7,193 | 4% | |||
Gross profit ........................................................ | $367,022 | $239,634 | $127,388 | 53% | |||
Gross margin ..................................................... | 68% | 60% |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Research and development ............................ | $122,386 | $132,442 | $(10,056) | (8%) |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Sales and marketing ........................................ | $218,722 | $220,511 | $(1,789) | (1%) |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
General and administrative ............................. | $133,552 | $133,023 | $529 | NM |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Interest expense ............................................... | $(75,997) | $(63,281) | $(12,716) | 20% |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Other income (expense), net .......................... | $(73) | $10,093 | $(10,166) | (101%) |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Gain (loss) on fair value adjustments ............ | $12,200 | $(26,594) | $38,794 | NM |
Year Ended January 31, | |||||||
2025 | 2024 | Change | % Change | ||||
(dollars in thousands) | |||||||
Income tax expense ......................................... | $9,570 | $5,428 | $4,142 | 76% |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(dollars in thousands) | |||||||
GAAP gross profit ............................................. | $367,022 | $239,634 | $236,830 | $171,182 | |||
GAAP gross margin ......................................... | 68% | 60% | 72% | 67% | |||
Stock-based compensation-related charges .............................................................. | 4,577 | 4,751 | 2,110 | 1,842 | |||
Amortization of intangible assets ................... | 256 | 1,526 | 85 | 128 | |||
Restructuring and facility exit costs ............... | — | 3,318 | — | — | |||
Non-GAAP gross profit .................................... | $371,855 | $249,229 | $239,025 | $173,152 | |||
Non-GAAP gross margin ................................. | 69% | 62% | 73% | 68% |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
GAAP loss from operations ............................ | $(107,638) | $(246,342) | $(28,151) | $(55,370) | |||
Stock-based compensation expense- related charges ............................................. | 77,379 | 75,851 | 36,597 | 35,292 | |||
Amortization of intangible assets ................... | 5,217 | 6,364 | 2,630 | 2,593 | |||
Deferred offering costs write-off ..................... | — | 3,749 | — | — | |||
Restructuring and facility exit costs ............... | — | 8,577 | — | — | |||
Reversal of tax contingency ........................... | — | (22,952) | — | — | |||
Non-GAAP income (loss) from operations ... | $(25,042) | $(174,753) | $11,076 | $(17,485) |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
GAAP net loss ................................................... | $(181,078) | $(331,552) | $(99,880) | $(92,544) | |||
Stock-based compensation expense- related charges .......................................... | 77,379 | 75,851 | 36,597 | 35,292 | |||
Amortization of intangible assets ................... | 5,217 | 6,364 | 2,630 | 2,593 | |||
Amortization of debt discount and debt issuance costs ........................................... | 12,211 | 14,736 | 2,984 | 7,510 | |||
Deferred offering costs write-off ..................... | — | 3,749 | — | — | |||
Gain (loss) on fair value adjustments ............ | (12,200) | 26,594 | 17,886 | (3,020) | |||
Restructuring and facility exit costs ............... | — | 8,577 | — | — | |||
Reversal of tax contingency ........................... | — | (29,652) | — | — | |||
SAFE debt issuance costs expensed ........... | — | — | 2,913 | — | |||
Loss on extinguishment of debt ..................... | — | — | 20,528 | — | |||
Non-GAAP provision for income taxes ......... | 2,084 | 980 | 1,567 | 756 | |||
Non-GAAP net loss .......................................... | $(96,387) | $(224,353) | $(14,775) | $(49,413) |
Three Months Ended | |||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | ||||||||||
(in thousands) | |||||||||||||||||||
Revenue .................. | $94,184 | $99,373 | $110,300 | $98,399 | $120,942 | $132,785 | $151,118 | $131,992 | $157,461 | $171,952 | |||||||||
Cost of revenue ...... | 41,541 | 39,655 | 40,702 | 40,724 | 41,162 | 41,383 | 44,522 | 42,748 | 45,668 | 46,915 | |||||||||
Gross profit ....... | 52,643 | 59,718 | 69,598 | 57,675 | 79,780 | 91,402 | 106,596 | 89,244 | 111,793 | 125,037 | |||||||||
Operating expenses | |||||||||||||||||||
Research and development | 33,388 | 34,350 | 32,709 | 31,995 | 28,796 | 28,988 | 33,000 | 31,602 | 31,402 | 33,358 | |||||||||
Sales and marketing ..... | 52,967 | 52,514 | 57,061 | 57,969 | 49,364 | 54,166 | 58,086 | 57,106 | 61,880 | 68,496 | |||||||||
General and administrativ e ..................... | 17,510 | 39,583 | 41,245 | 34,685 | 32,590 | 32,648 | 34,968 | 33,346 | 34,405 | 35,440 | |||||||||
Total operating expense .............. | 103,865 | 126,447 | 131,015 | 124,649 | 110,750 | 115,802 | 126,054 | 122,054 | 127,687 | 137,294 | |||||||||
Loss from operations .......... | (51,222) | (66,729) | (61,417) | (66,974) | (30,970) | (24,400) | (19,458) | (32,810) | (15,894) | (12,257) | |||||||||
Interest expense ........ | (12,480) | (15,650) | (16,604) | (18,547) | (18,097) | (19,754) | (19,658) | (18,488) | (16,336) | (15,635) | |||||||||
Other income (expense), net ................. | 7,869 | (95) | (608) | 2,927 | 129 | 1,824 | 1,022 | (3,048) | 6,119 | 580 | |||||||||
Loss on extinguishm ent of debt .... | — | — | — | — | — | — | — | — | (20,528) | — | |||||||||
Gain (loss) on fair value adjustments . | (13,562) | 1,353 | (12,625) | (1,760) | 1,510 | 1,510 | 1,381 | 7,799 | (10,136) | (7,750) | |||||||||
Loss before income tax expense .............. | (69,395) | (81,121) | (91,254) | (84,354) | (47,428) | (40,820) | (36,713) | (46,547) | (56,775) | (35,062) | |||||||||
Income tax expense .............. | 688 | 1,700 | 1,562 | 1,478 | 2,202 | 2,094 | 5,169 | 105 | 4,482 | 3,561 | |||||||||
Net loss .................... | $(70,083) | $(82,821) | $(92,816) | $(85,832) | $(49,630) | $(42,914) | $(41,882) | $(46,652) | $(61,257) | $(38,623) |
Three Months Ended | |||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | ||||||||||
Revenue ............................ | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |||||||||
Cost of revenue ................ | 44 | 40 | 37 | 41 | 34 | 31 | 29 | 32 | 29 | 27 | |||||||||
Gross profit ................. | 56 | 60 | 63 | 59 | 66 | 69 | 71 | 68 | 71 | 73 | |||||||||
Operating expenses | |||||||||||||||||||
Research and development .......... | 35 | 35 | 30 | 33 | 24 | 22 | 22 | 24 | 20 | 19 | |||||||||
Sales and marketing . | 56 | 53 | 52 | 59 | 41 | 41 | 38 | 43 | 39 | 40 | |||||||||
General and administrative ........ | 19 | 40 | 37 | 35 | 27 | 25 | 23 | 25 | 22 | 21 | |||||||||
Total operating expense . | 110 | 128 | 119 | 127 | 92 | 88 | 83 | 92 | 81 | 80 | |||||||||
Loss from operations ....... | (54) | (68) | (56) | (68) | (26) | (19) | (12) | (24) | (10) | (7) | |||||||||
Interest expense ........ | (13) | (16) | (15) | (19) | (15) | (15) | (13) | (14) | (10) | (9) | |||||||||
Other income (expense), net ....... | 8 | — | (1) | 3 | — | 1 | 1 | (2) | 4 | — | |||||||||
Loss on extinguishment of debt ......................... | — | — | — | — | — | — | — | — | (13) | — | |||||||||
Gain (loss) on fair value adjustments | (14) | 1 | (11) | (2) | 1 | 1 | 1 | 6 | (6) | (5) | |||||||||
Loss before income tax expense ........................ | (73) | (83) | (83) | (86) | (40) | (32) | (23) | (34) | (35) | (21) | |||||||||
Income tax expense ........ | 1 | 2 | 1 | 2 | 2 | 2 | 3 | — | 3 | 2 | |||||||||
Net loss .............................. | (74)% | (85)% | (84)% | (88)% | (42)% | (34)% | (26)% | (34)% | (38)% | (23)% |
Three Months Ended | |||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | ||||||||||
(in thousands) | |||||||||||||||||||
Usage-based revenue ................. | $87,777 | $91,895 | $102,197 | $89,859 | $110,996 | $121,452 | $139,205 | $118,703 | $143,149 | $156,549 | |||||||||
Subscription revenue ................. | 6,407 | 7,478 | 8,103 | 8,540 | 9,946 | 11,333 | 11,913 | 13,289 | 14,312 | 15,403 | |||||||||
Total revenue ... | $94,184 | $99,373 | $110,300 | $98,399 | $120,942 | $132,785 | $151,118 | $131,992 | $157,461 | $171,952 |
Three Months Ended | |||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | ||||||||||
(dollars in thousands) | |||||||||||||||||||
GAAP gross profit ........ | $52,643 | $59,718 | $69,598 | $57,675 | $79,780 | $91,402 | $106,596 | $89,244 | $111,793 | $125,037 | |||||||||
GAAP gross margin ..... | 56% | 60% | 63% | 59% | 66% | 69% | 71% | 68% | 71% | 73% | |||||||||
Stock-based compensation expense-related charges ..................... | 1,379 | 1,254 | 921 | 1,197 | 911 | 931 | 1,683 | 1,052 | 1,047 | 1,063 | |||||||||
Amortization of intangible assets ..... | 1,356 | 43 | 64 | 63 | 64 | 64 | 64 | 64 | 63 | 22 | |||||||||
Restructuring and facility exit costs ...... | 3,203 | — | — | 115 | — | — | — | — | — | — | |||||||||
Non-GAAP gross profit .......................... | $58,581 | $61,015 | $70,583 | $59,050 | $80,755 | $92,397 | $108,343 | $90,360 | $112,903 | $126,122 | |||||||||
Non-GAAP gross margin ....................... | 62% | 61% | 64% | 60% | 67% | 70% | 72% | 68% | 72% | 73% |
Three Months Ended | |||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | ||||||||||
(in thousands) | |||||||||||||||||||
GAAP loss from operations ................ | $(51,222) | $(66,729) | $(61,417) | $(66,974) | $(30,970) | $(24,400) | $(19,458) | $(32,810) | $(15,894) | $(12,257) | |||||||||
Stock-based compensation expense-related charges ..................... | 18,610 | 20,993 | 19,169 | 17,079 | 17,911 | 17,381 | 24,576 | 17,511 | 17,260 | 19,337 | |||||||||
Amortization of intangible assets ..... | 2,544 | 1,265 | 1,267 | 1,288 | 1,284 | 1,309 | 1,348 | 1,276 | 1,310 | 1,320 | |||||||||
Deferred offering costs write-off | — | — | 3,749 | — | — | — | — | — | — | — | |||||||||
Restructuring and facility exit costs ...... | 5,713 | 40 | — | 2,824 | — | — | — | — | — | — | |||||||||
Reversal of tax contingency .............. | (22,952) | — | — | — | — | — | — | — | — | — | |||||||||
Non-GAAP income (loss) from operations ................ | $(47,307) | $(44,431) | $(37,232) | $(45,783) | $(11,775) | $(5,710) | $6,466 | $(14,023) | $2,676 | $8,400 |
Three Months Ended | Twelve Months Ended July 31, | ||||||||||||||||||||
April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | October 31, | January 31, | April 30, | July 31, | ||||||||||||
2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2025 | 2025 | |||||||||||
(in thousands) | |||||||||||||||||||||
GAAP net loss .......... | $(70,083) | $(82,821) | $(92,816) | $(85,832) | $(49,630) | $(42,914) | $(41,882) | $(46,652) | $(61,257) | $(38,623) | $(188,414) | ||||||||||
Stock-based compensation expense-related charges ................. | 18,610 | 20,993 | 19,169 | 17,079 | 17,911 | 17,381 | 24,576 | 17,511 | 17,260 | 19,337 | 78,684 | ||||||||||
Amortization of intangible assets . | 2,544 | 1,265 | 1,267 | 1,288 | 1,284 | 1,309 | 1,348 | 1,276 | 1,310 | 1,320 | 5,254 | ||||||||||
Amortization of debt discount and debt issuance costs | 3,396 | 3,893 | 3,718 | 3,729 | 3,654 | 3,856 | 2,735 | 1,966 | 1,434 | 1,550 | 7,685 | ||||||||||
Deferred offering costs write-off ...... | — | — | 3,749 | — | — | — | — | — | — | — | — | ||||||||||
Gain (loss) on fair value adjustments ......... | 13,562 | (1,353) | 12,625 | 1,760 | (1,510) | (1,510) | (1,381) | (7,799) | 10,136 | 7,750 | 8,706 | ||||||||||
Restructuring and facility exit costs .. | 5,713 | 40 | — | 2,824 | — | — | — | — | — | — | — | ||||||||||
Reversal of tax contingency .......... | (29,652) | — | — | — | — | — | — | — | — | — | — | ||||||||||
SAFE debt issuance costs expensed ... | — | — | — | — | — | — | — | — | 2,913 | — | 2,913 | ||||||||||
Loss on extinguishment of debt ....................... | — | — | — | — | — | — | — | — | 20,528 | — | 20,528 | ||||||||||
Non-GAAP provision for income taxes .. | 218 | 240 | 259 | 263 | 368 | 388 | 682 | 646 | 604 | 963 | 2,895 | ||||||||||
Non-GAAP net loss .. | $(55,692) | $(57,743) | $(52,029) | $(58,889) | $(27,923) | $(21,490) | $(13,922) | $(33,052) | $(7,072) | $(7,703) | $(61,749) |
Year Ended January 31, | Six Months Ended July 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in thousands) | |||||||
Net cash provided by (used in) operating activities .......................................................... | $(50,406) | $(166,363) | $4,784 | $(29,033) | |||
Net cash provided by (used in) investing activities .......................................................... | $44,870 | $(108,779) | $(11,055) | $26,072 | |||
Net cash provided by financing activities ..... | $52,554 | $212,620 | $6,606 | $51,415 |
Name | Age | Position(s) | ||
Executive Officers: | ||||
Ariel Cohen ............................ | 50 | Chairperson of our board of directors and Chief Executive Officer | ||
Ilan Twig ................................. | 51 | Director and Chief Technology Officer | ||
Amy Butte ............................... | 57 | Chief Financial Officer | ||
Michael Sindicich .................. | 33 | President | ||
Non-Employee Directors: | ||||
Ben Horowitz(2)(4) ................... | 59 | Director | ||
Arif Janmohamed(1) .............. | 49 | Director | ||
Michael Kourey(1)(2) ............... | 66 | Director | ||
Clara Liang(2)(3) ...................... | 45 | Director | ||
Sandesh Patnam(1) ............... | 51 | Director | ||
Anré Williams(3) ..................... | 60 | Director | ||
Oren Zeev(1) ........................... | 60 | Director |
Name | Stock Awards ($) | Option Awards ($)(2) | Total ($) | |||
Ben Horowitz ............................................................................... | — | — | — | |||
Arif Janmohamed ....................................................................... | — | — | — | |||
Clara Liang .................................................................................. | — | 59,661 | 59,661 | |||
Michael Kourey(1) ........................................................................ | — | — | — | |||
Sandesh Patnam ........................................................................ | — | — | — | |||
Anré Williams .............................................................................. | — | — | — | |||
Oren Zeev .................................................................................... | — | — | — |
Name and Principal Position | Year | Salary($) | Stock Awards($)(1) | Option Awards($)(2) | All Other Compensati on ($)(3) | Total($) | ||||||
Ariel Cohen, Co-founder, Chairperson of our board of directors, and Chief Executive Officer ............ | 2025 | 816,667 | — | 812,921 | 252 | 1,629,840 | ||||||
Ilan Twig, Co-founder, a member of our board of directors, and Chief Technology Officer(4) ........................... | 2025 | 575,357 | — | 900,087 | 30 | 1,475,474 | ||||||
Michael Sindicich, President ............................. | 2025 | 750,000 | — | 1,363,642 | 252 | 2,113,894 |
Name | Shares underlying repriced options | Exercise prices prior to repricing | Exercise price of repriced options | |||
Ariel Cohen ........................................ | 694,443 | $20.73 | $16.26 | |||
Ilan Twig ............................................. | 867,519 | $19.98 - $20.73 | $16.26 | |||
Michael Sindicich .............................. | 166,666 | $20.73 | $16.26 |
Option Awards(1) | Stock Awards(1) | |||||||||||||||
Name | Vesting Commencement Date | Grant Date | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price($)(2) | Option Expiration Date | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3) | ||||||||
Ariel Cohen ..... | 02/01/2021(4)(5) | 03/18/2021 | 1,594,752 | — | 10.05 | 03/17/2031 | — | — | ||||||||
02/01/2023(4)(6) | 4/14/2022 | 665,789 | 997,873 | 16.26 | 04/13/2032 | — | — | |||||||||
02/01/2023(4)(6)(7) | 04/13/2023 | 210,960 | 316,184 | 16.26 | 04/12/2033 | — | — | |||||||||
Ilan Twig .......... | 02/01/2021(5) | 03/18/2021 | 2,072,340 | — | 10.05 | 03/17/2031 | — | — | ||||||||
02/01/2023(6)(7) | 01/17/2023 | 319,444 | 347,222 | 16.26 | 01/16/2033 | — | — | |||||||||
02/01/2023(6)(7) | 04/13/2023 | 96,242 | 104,611 | 16.26 | 04/12/2033 | — | — | |||||||||
Michael Sindicich ..... | 09/14/2018(8) | 09/16/2018 | 49,758 | — | 0.6825 | 09/15/2028 | — | — | ||||||||
04/01/2020(9) | 05/30/2020 | 33,333 | — | 4.29 | 05/29/2030 | — | — | |||||||||
02/06/2021(10) | 03/18/2021 | 248,055 | 5,278 | 10.05 | 03/17/2031 | — | — | |||||||||
02/01/2022(11) | 04/14/2022 | 243,517 | 90,449 | 16.26 | 04/13/2032 | — | — | |||||||||
02/01/2023(7)(11) | 04/13/2023 | 79,861 | 86,805 | 16.26 | 04/12/2033 | — | — | |||||||||
12/01/2023(12) | 01/25/2024 | 117,361 | 315,972 | 16.26 | 01/24/2034 | — | — | |||||||||
12/20/2024(13) | 01/22/2025 | — | — | — | — | 93,483 | 704,861 | |||||||||
12/01/2024(12) | 01/22/2025 | — | 87,565 | 20.31 | 01/21/2035 | — | — |
Stockholder | Shares of Series G Redeemable Convertible Preferred Stock | Shares of Series G-1 Redeemable Convertible Preferred Stock | Total Purchase Price(1) | |||
Entities affiliated with Andreessen Horowitz(2) ....................... | — | 400,547 | $14,999,989 | |||
Entities affiliated with Lightspeed Venture Partners(3) .......... | — | 400,544 | $14,999,952 | |||
Entities affiliated with Zeev Ventures(4) ................................... | — | 133,515 | $4,999,988 | |||
Entities affiliated with Premji Invest(5) ...................................... | 2,670,319 | — | $99,999,988 |
Percentage of Shares Beneficially Owned Before the Offering | Shares of Class A Common Stock Being Offered | Percentage of Shares Beneficially Owned After the Offering | Percentage of Total Voting Power After the Offering** | |||||||||||
Name of Beneficial Owner | Class A Common Stock | Class B Common Stock | Class A Common Stock | Class B Common Stock | Class A Common Stock | Class B Common Stock | ||||||||
Named Executive Officers and Directors: | ||||||||||||||
Ariel Cohen(1) .................... | ||||||||||||||
Ilan Twig(2) ......................... | ||||||||||||||
Michael Sindicich(3) .......... | ||||||||||||||
Ben Horowitz(4) .................. | ||||||||||||||
Arif Janmohamed(5) .......... | ||||||||||||||
Michael Kourey(6) .............. | ||||||||||||||
Clara Liang(7) ..................... | ||||||||||||||
Sandesh Patnam(8) ........... | ||||||||||||||
Anré Williams .................... | ||||||||||||||
Oren Zeev(9) ...................... | ||||||||||||||
All executive officers and directors as a group (11 persons)(10) ............. | ||||||||||||||
Other 5% or Greater Stockholders: | ||||||||||||||
Entities affiliated with Lightspeed Venture Partners(11) .................... | ||||||||||||||
Entities affiliated with Andreessen Horowitz(12) .................... | ||||||||||||||
Entities affiliated with Zeev Ventures(13) ......... |
Earliest Date Available for Sale in the Public Market | Number of Shares of Common Stock |
The opening of trading on the first trading day following a 10-consecutive trading day period during which the closing price of our Class A common stock on Nasdaq exceeds 130% of the initial public offering price per share set forth on the cover page of this prospectus for at least five trading days (one of which must be a trading day following our public release of earnings for the fiscal quarter ending October 31, 2025, referred to as the Initial Earnings Release) out of such 10-consecutive trading day period. | Up to shares held by Eligible Stockholders (as defined below). |
The opening of trading on the second full trading day following our public release of earnings for the fiscal quarter and fiscal year ending January 31, 2026, referred to as the Second Earnings Release. | All remaining shares held by our stockholders that were not previously eligible for sale under the lock-up agreements, subject to applicable limitations under Rule 144, including for “affiliates” and compliance with other applicable law, as described below. |
Underwriters | Number of Shares | |
Goldman Sachs & Co. LLC ............................................................................................................ | ||
Citigroup Global Markets Inc. ......................................................................................................... | ||
Jefferies LLC ..................................................................................................................................... | ||
Mizuho Securities USA LLC ........................................................................................................... | ||
Morgan Stanley & Co. LLC .............................................................................................................. | ||
BNP Paribas Securities Corp. ........................................................................................................ | ||
Citizens JMP Securities, LLC ......................................................................................................... | ||
Oppenheimer & Co. Inc. .................................................................................................................. | ||
MUFG Securities Americas Inc. ...................................................................................................... | ||
Needham & Company, LLC ........................................................................................................... | ||
BTIG, LLC ......................................................................................................................................... | ||
Loop Capital Markets LLC ............................................................................................................... | ||
Academy Securities, Inc. ................................................................................................................ | ||
Rosenblatt Securities Inc. ................................................................................................................ | ||
Total ................................................................................................................................................... |
No Exercise | Full Exercise | ||
Per Share ................................................................................................................ | $ | $ | |
Total .................................................................................................................... | $ | $ |
Page | |
Consolidated Financial Statements as of and for the Years Ended January 31, 2025 and 2024 | |
Report of Independent Registered Public Accounting Firm ............................................................... | |
Consolidated Balance Sheets ................................................................................................................. | |
Consolidated Statements of Operations ................................................................................................ | |
Consolidated Statements of Comprehensive Loss .............................................................................. | |
Deficit ........................................................................................................................................................... | |
Consolidated Statements of Cash Flows ............................................................................................... | |
Notes to Consolidated Financial Statements ........................................................................................ |
Unaudited Condensed Consolidated Financial Statements as of January 31, 2025 and July 31, 2025 and for the Six Months Ended July 31, 2025 and 2024 | |
Condensed Consolidated Balance Sheets ............................................................................................ | |
Condensed Consolidated Statements of Operations .......................................................................... | |
Condensed Consolidated Statements of Comprehensive Loss ........................................................ | |
Stockholders’ Deficit ................................................................................................................................. | |
Condensed Consolidated Statements of Cash Flows ......................................................................... | |
Notes to Condensed Consolidated Financial Statements .................................................................. |
As of January 31, | |||
2025 | 2024 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents ............................................................................................. | $157,672 | $166,421 | |
Restricted cash, current .................................................................................................. | 148,157 | 95,961 | |
Accounts receivable, net ................................................................................................. | 184,856 | 158,355 | |
Corporate card receivables, net ..................................................................................... | 157,755 | 224,278 | |
Contract acquisition costs, current ................................................................................ | 4,784 | 2,884 | |
Prepaid expenses and other current assets ................................................................ | 35,628 | 34,664 | |
Total current assets ............................................................................................................... | 688,852 | 682,563 | |
Restricted cash, non-current ................................................................................................ | 4,766 | 5,000 | |
Contract acquisition costs, non-current .............................................................................. | 16,185 | 47 | |
Operating lease right-of-use assets .................................................................................... | 48,006 | 45,877 | |
Property, equipment and software, net .............................................................................. | 29,538 | 31,183 | |
Intangible assets, net ............................................................................................................ | 55,633 | 61,012 | |
Goodwill ................................................................................................................................... | 219,728 | 220,541 | |
Other non-current assets ...................................................................................................... | 21,246 | 19,794 | |
Total assets ............................................................................................................................ | $1,083,954 | $1,066,017 | |
Liabilities, redeemable convertible preferred stock and stockholders’ deficit | |||
Current liabilities: | |||
Accounts payable ............................................................................................................. | $42,829 | $24,320 | |
Accrued expenses and other current liabilities ............................................................ | 136,798 | 127,242 | |
Notes payable, current .................................................................................................... | 175,913 | 2,594 | |
Trade loan facility ............................................................................................................. | 45,000 | — | |
Operating lease liabilities, current ................................................................................. | 11,389 | 5,734 | |
Deferred revenue, current ............................................................................................... | 34,097 | 27,794 | |
Total current liabilities ........................................................................................................... | 446,026 | 187,684 | |
Operating lease liabilities, non-current ............................................................................... | 43,098 | 45,258 | |
Convertible notes, net ........................................................................................................... | 182,394 | 154,687 | |
Embedded derivative liability ............................................................................................... | 59,820 | 72,150 | |
Warehouse credit facility ...................................................................................................... | 214,238 | 206,404 | |
Notes payable, non-current .................................................................................................. | 394 | 159,170 | |
Deferred revenue, non-current ............................................................................................ | 813 | 330 | |
Other non-current liabilities .................................................................................................. | 22,949 | 21,184 | |
Total liabilities ......................................................................................................................... | 969,732 | 846,867 | |
Commitments and contingencies (Note 13) | |||
Redeemable convertible preferred stock, par value $0.00000625; 157,027,585 shares authorized; 146,360,207 issued and outstanding (aggregate liquidation preference of $1,301,402) .............................................................................................. | 1,301,121 | 1,301,121 | |
Stockholders’ deficit | |||
Common stock, par value $0.00000625 per share; 253,919,000 shares authorized, 45,782,871 and 45,117,008 shares issued and outstanding as of January 31, 2025 and 2024, respectively ......................................................... | 1 | 1 | |
Additional paid-in capital ................................................................................................. | 467,835 | 382,356 | |
Accumulated deficit .......................................................................................................... | (1,617,113) | (1,436,035) | |
Accumulated other comprehensive loss ....................................................................... | (37,622) | (28,293) | |
Total stockholders’ deficit ..................................................................................................... | (1,186,899) | (1,081,971) | |
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit ..... | $1,083,954 | $1,066,017 |
Year Ended January 31, | |||
2025 | 2024 | ||
Revenue ................................................................................................................... | $536,837 | $402,256 | |
Cost of revenue ....................................................................................................... | 169,815 | 162,622 | |
Gross profit ............................................................................................................... | 367,022 | 239,634 | |
Operating expenses | |||
Research and development ............................................................................. | 122,386 | 132,442 | |
Sales and marketing .......................................................................................... | 218,722 | 220,511 | |
General and administrative ............................................................................... | 133,552 | 133,023 | |
Total operating expenses ...................................................................................... | 474,660 | 485,976 | |
Loss from operations .............................................................................................. | (107,638) | (246,342) | |
Interest expense ................................................................................................. | (75,997) | (63,281) | |
Other income (expense), net ............................................................................ | (73) | 10,093 | |
Gain (loss) on fair value adjustments ............................................................. | 12,200 | (26,594) | |
Loss before income tax expense .......................................................................... | (171,508) | (326,124) | |
Income tax expense ............................................................................................... | 9,570 | 5,428 | |
Net loss ..................................................................................................................... | $(181,078) | $(331,552) | |
Net loss per share attributable to common stockholders: | |||
Basic and diluted net loss per share .................................................................... | $(4.00) | $(7.44) | |
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted ............................... | 45,271,666 | 44,583,919 |
Year Ended January 31, | |||
2025 | 2024 | ||
Net loss ..................................................................................................................... | $(181,078) | $(331,552) | |
Other comprehensive income (loss), net of tax: | |||
Foreign currency translation adjustments ........................................................... | (9,329) | 6,611 | |
Total other comprehensive income (loss), net of tax ........................................ | (9,329) | 6,611 | |
Total comprehensive loss ...................................................................................... | $(190,407) | $(324,941) |
Accumulated | ||||||||||||||||
Additional | other | Total | ||||||||||||||
Redeemable Convertible Preferred Stock | Common Stock | paid-in | Accumulated | comprehensive | stockholders' | |||||||||||
Shares | Amount | Shares | Amount | capital | deficit | income (loss) | deficit | |||||||||
Balance as of January 31, 2023 ........................................................ | 146,360,207 | $1,301,121 | 44,295,279 | $1 | $298,663 | $(1,104,483) | $(34,904) | $(840,723) | ||||||||
Net loss ............................................................................................... | — | — | — | — | — | (331,552) | — | (331,552) | ||||||||
Other comprehensive income, net of tax ...................................... | — | — | — | — | — | — | 6,611 | 6,611 | ||||||||
Issuance of common stock upon exercise of stock options....... | — | — | 821,729 | — | 6,400 | — | — | 6,400 | ||||||||
Vesting of early exercised stock options ....................................... | — | — | — | — | 312 | — | — | 312 | ||||||||
Stock-based compensation ............................................................. | — | — | — | — | 76,981 | — | — | 76,981 | ||||||||
Balance as of January 31, 2024 ........................................................ | 146,360,207 | $1,301,121 | 45,117,008 | $1 | $382,356 | $(1,436,035) | $(28,293) | $(1,081,971) | ||||||||
Net loss ............................................................................................... | — | — | — | — | — | (181,078) | — | (181,078) | ||||||||
Other comprehensive loss, net of tax ............................................ | — | — | — | — | — | — | (9,329) | (9,329) | ||||||||
Issuance of common stock upon exercise of stock options ...... | — | — | 665,863 | — | 4,521 | — | — | 4,521 | ||||||||
Vesting of early exercised stock options ...................................... | — | — | — | — | 1,658 | — | — | 1,658 | ||||||||
Stock-based compensation ............................................................. | — | — | — | — | 79,300 | — | — | 79,300 | ||||||||
Balance as of January 31, 2025 ....................................................... | 146,360,207 | $1,301,121 | 45,782,871 | $1 | $467,835 | $(1,617,113) | $(37,622) | $(1,186,899) |
Year Ended January 31, | |||
2025 | 2024 | ||
Cash flows from operating activities: | |||
Net loss ................................................................................................................ | $(181,078) | $(331,552) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||
Stock-based compensation, net of amounts capitalized ......................... | 76,981 | 75,851 | |
Non-cash interest expense .......................................................................... | 46,450 | 44,647 | |
Deferred income taxes ................................................................................. | 1 | (3,224) | |
Depreciation and amortization .................................................................... | 24,889 | 26,864 | |
Amortization of contract acquisition costs ................................................. | 5,647 | 7,033 | |
Provision for doubtful accounts ................................................................... | 5,912 | 8,693 | |
Loss (gain) on fair value adjustments ........................................................ | (12,200) | 26,594 | |
Other ................................................................................................................ | 365 | 159 | |
Changes in operating assets and liabilities, net of effect of business acquisitions: | |||
Accounts receivable ................................................................................. | (24,614) | (21,149) | |
Prepaid expenses and other current assets ......................................... | (1,117) | 1,784 | |
Contract acquisition costs ....................................................................... | (23,685) | — | |
Other non-current assets ......................................................................... | (1,302) | (6,933) | |
Accounts payable ..................................................................................... | 17,093 | (9,630) | |
Accrued expenses and other current liabilities .................................... | 6,647 | 33,170 | |
Deferred revenue ...................................................................................... | 6,578 | 8,787 | |
Operating lease right-of-use asset and operating lease liabilities, net ........................................................................................................ | 2,256 | 173 | |
Other non-current liabilities ..................................................................... | 771 | (27,630) | |
Net cash used in operating activities ................................................ | (50,406) | (166,363) | |
Cash flows from investing activities: | |||
Capitalized software development costs ................................................... | (15,309) | (16,743) | |
Purchases of property and equipment ....................................................... | (994) | (561) | |
Cash consideration paid for business acquisition, net of cash acquired ..................................................................................................... | (3,879) | (7,026) | |
(Increase) decrease in corporate card receivables .................................. | 65,052 | (84,449) | |
Net cash provided by (used in) investing activities ........................ | 44,870 | (108,779) | |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock from exercise of stock- based awards ............................................................................................ | 4,540 | 9,059 | |
Proceeds from borrowings of debt .............................................................. | 86,187 | 206,419 | |
Payments of borrowings of debt ................................................................. | (35,758) | (725) | |
Payments for debt issuance cost ................................................................ | (1,512) | — | |
Payments of deferred consideration in business combinations ............. | (903) | (2,133) | |
Net cash provided by financing activities ......................................... | 52,554 | 212,620 | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash ................................................................................. | (3,805) | (414) | |
Net increase (decrease) in cash, cash equivalents and restricted cash ................................................................................. | 43,213 | (62,936) | |
Cash, cash equivalents and restricted cash, beginning of period ................... | $267,382 | $330,318 |
Year Ended January 31, | |||
2025 | 2024 | ||
Cash, cash equivalents and restricted cash, end of period ............................. | $310,595 | $267,382 | |
Supplemental disclosure of cash flow information: | |||
Cash paid for interest .................................................................................... | $29,547 | $18,634 | |
Cash paid for income taxes ......................................................................... | $8,539 | $6,368 | |
Noncash investing and financing activities: | |||
Vesting of early exercised stock options ................................................... | $1,658 | $312 | |
Capitalized share-based compensation for internal-use software development costs ................................................................................... | $2,319 | $1,130 | |
Amounts unpaid for purchases of property and equipment .................... | $12 | $556 |
As of January 31, | |||
2025 | 2024 | ||
Cash and cash equivalents ................................................................................... | $157,672 | $166,421 | |
Restricted cash, current ......................................................................................... | 148,157 | 95,961 | |
Restricted cash, non-current ................................................................................. | 4,766 | 5,000 | |
Total cash and cash equivalents and restricted cash .................................. | $310,595 | $267,382 |
As of January 31, | |||
2025 | 2024 | ||
Balance at beginning of period ........................................................................ | $4,270 | $2,270 | |
Provision for expected credit losses ............................................................... | 3,764 | 4,488 | |
Amounts written off, recoveries and other adjustments ............................... | (2,899) | (2,488) | |
Balance at end of period .................................................................................... | $5,135 | $4,270 |
As of January 31, | |||
2025 | 2024 | ||
Balance at beginning of period ........................................................................ | $566 | $595 | |
Provision for expected credit losses ............................................................... | 2,296 | 3,332 | |
Amounts written off, recoveries and other adjustments ............................... | (2,482) | (3,361) | |
Balance at end of period .................................................................................... | $380 | $566 |
Property, Equipment and Software | Useful Life | |
Internal-use software | 3 years | |
Computers and equipment | 3 to 5 years | |
Fixtures and fittings | 3 to 5 years | |
Leasehold improvements | Shorter of useful life or remaining lease term |
Intangible Assets | Useful Life | |
Trade names | 3-19 years | |
Domain names | 15 years | |
Customer relationships | 5-13 years | |
Developed technology | 1-2 years |
As of January 31, | |||
2025 | 2024 | ||
United States ........................................................................................................... | $59,181 | $62,883 | |
United Kingdom ....................................................................................................... | 10,633 | 8,302 | |
All other countries ................................................................................................... | 7,730 | 5,875 | |
Total long-lived assets, net ............................................................................... | $77,544 | $77,060 |
Year Ended January 31, | |||
2025 | 2024 | ||
Usage-based revenue ............................................................................................ | $490,356 | $371,728 | |
Subscription revenue .............................................................................................. | 46,481 | 30,528 | |
Total revenue ...................................................................................................... | $536,837 | $402,256 |
Year Ended January 31, | |||||||
2025 | 2024 | ||||||
Amount | Percentage of Revenue | Amount | Percentage of Revenue | ||||
United States ..................................................... | $315,807 | 59% | $217,427 | 54% | |||
United Kingdom ................................................ | 129,412 | 24% | 115,234 | 29% | |||
Rest of World(1) ................................................. | 91,618 | 17% | 69,595 | 17% | |||
Total revenue ............................................... | $536,837 | 100% | $402,256 | 100% |
Fair value measurements as of January 31, 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
Financial Liabilities | |||||||
Redeemable convertible preferred stock warrant liability .................................................. | $— | $— | $427 | $427 | |||
Embedded derivative liability ......................... | — | — | 59,820 | 59,820 | |||
Total .................................................................... | $— | $— | $60,247 | $60,247 |
Fair value measurements as of January 31, 2024 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
Financial Liabilities: | |||||||
Redeemable convertible preferred stock warrant liability ............................................... | $— | $— | $297 | $297 | |||
Embedded derivative liability ......................... | — | — | 72,150 | 72,150 | |||
Total .............................................................. | $— | $— | $72,447 | $72,447 |
Year Ended January 31, | |||
2025 | 2024 | ||
Volatility .................................................................................................................... | 55.0 - 65.0% | 64.5 - 69.5% | |
Risk-free interest rate ............................................................................................. | 4.06 - 4.82% | 3.61 - 4.86% | |
Expected term (in years) ........................................................................................ | 3.9 - 4.4 | 4.9 - 5.4 | |
Dividend yield .......................................................................................................... | —% | —% |
Balance as of January 31, 2023 ...................................................................................................... | $433 |
Change in fair value ........................................................................................................................... | (136) |
Balance as of January 31, 2024 ...................................................................................................... | 297 |
Change in fair value ........................................................................................................................... | 130 |
Balance as of January 31, 2025 ...................................................................................................... | $427 |
Year Ended January 31, | |||
2025 | 2024 | ||
Time to expiration (in years) .......................................................................... | 0.70 - 1.70 | 1.17 - 2.17 | |
Time from conversion to maturity (in years) ............................................... | 0.65 - 1.65 | 0.19 - 1.19 | |
Discount factor ................................................................................................. | 9.0% | 10.5% | |
Volatility ............................................................................................................. | 57.8% - 72.6% | 66.1% - 85.3% | |
Risk free rate .................................................................................................... | 4.12% - 4.15% | 4.23% - 4.65% |
Balance as of January 31, 2023 ...................................................................................................... | $45,420 |
Change in fair value ........................................................................................................................... | 26,730 |
Balance as of January 31, 2024 ...................................................................................................... | 72,150 |
Change in fair value ........................................................................................................................... | (12,330) |
Balance as of January 31, 2025 ...................................................................................................... | $59,820 |
Fair Value Hierarchy | As of January 31, | ||||
2025 | 2024 | ||||
Convertible notes ......................................................................... | Level 3 | $359,200 | $314,400 | ||
Warehouse credit facility ............................................................ | Level 3 | $210,995 | $200,238 | ||
Trade loan facility ......................................................................... | Level 3 | $45,000 | — | ||
2022 promissory note ................................................................. | Level 3 | $179,932 | $161,518 | ||
Other debt ..................................................................................... | Level 3 | $933 | $3,376 |
As of January 31, | |||
2025 | 2024 | ||
Capitalized software ............................................................................................... | $42,317 | $44,650 | |
Computers and equipment .................................................................................... | 7,349 | 6,738 | |
Fixtures and fittings ................................................................................................. | 3,561 | 4,252 | |
Leasehold improvements ....................................................................................... | 2,779 | 2,422 | |
Construction in progress(1) ..................................................................................... | 2,960 | 2,780 | |
Property, equipment and software, gross ...................................................... | 58,966 | 60,842 | |
Less: accumulated depreciation ........................................................................... | (29,428) | (29,659) | |
Property, equipment and software, net ........................................................... | $29,538 | $31,183 |
As of January 31, | |||
2025 | 2024 | ||
Prepaid expenses ................................................................................................... | $16,965 | $12,623 | |
Deposits .................................................................................................................... | 1,532 | 1,897 | |
Payment processor advances(1) ........................................................................... | 6,801 | 5,296 | |
Tax receivable ......................................................................................................... | 3,196 | 3,920 | |
Other current assets ............................................................................................... | 7,134 | 10,928 | |
Total prepaid expenses and other current assets | $35,628 | $34,664 |
As of January 31, | |||
2025 | 2024 | ||
Accrued compensation and employee benefits ................................................. | $28,970 | $31,863 | |
Accrued expenses .................................................................................................. | 37,319 | 40,922 | |
Amounts due to travel supply partners(1) ............................................................. | 31,700 | 23,195 | |
Reward liability(2) ..................................................................................................... | 11,408 | 12,463 | |
Corporate tax payable ............................................................................................ | 4,640 | 2,797 | |
Indirect tax payable ................................................................................................. | 3,489 | 4,148 | |
Early exercise liability ............................................................................................. | 976 | 2,625 | |
Accrued interest ...................................................................................................... | 2,642 | 2,270 | |
Other ......................................................................................................................... | 15,654 | 6,959 | |
Total accrued expenses and other current liabilities .................................... | $136,798 | $127,242 |
As of January 31, | |||
2025 | 2024 | ||
Loss contingency reserves(1) ................................................................................. | $8,120 | $5,548 | |
Deferred tax liability ................................................................................................ | 7,655 | 7,028 | |
Taxes payable for unrecognized tax benefits ..................................................... | 2,288 | 2,743 | |
Redeemable convertible preferred stock warrant liability ................................. | 427 | 297 | |
NOW Scheme contingency payable(2) ................................................................. | 3,806 | 5,119 | |
Other non-current liabilities ................................................................................... | 653 | 449 | |
Total other non-current liabilities ..................................................................... | $22,949 | $21,184 |
Year Ended January 31, | |||
2025 | 2024 | ||
Operating lease costs ............................................................................................. | $15,047 | $15,393 | |
Short-term lease costs ........................................................................................... | 3,234 | 6,467 | |
Variable lease costs ............................................................................................... | 2,139 | 1,853 | |
Total lease costs ................................................................................................ | $20,420 | $23,713 |
Year Ended January 31, | |||
2025 | 2024 | ||
Cash paid for amounts included in the measurement of operating lease liabilities ................................................................................................................ | $12,864 | $15,518 | |
Operating lease right-of-use assets obtained in exchange for lease obligations ............................................................................................................ | $9,773 | $22,507 | |
Increase (decrease) of lease liabilities due to lease modifications ................. | $2,240 | $(2,745) | |
Increase (decrease) of right-of-use assets due to lease modifications .......... | $3,032 | $(2,745) | |
Termination of operating lease liabilities ............................................................. | $909 | $321 | |
Termination of operating lease right-of-use assets ........................................... | $806 | $284 |
As of January 31, | |||
2025 | 2024 | ||
Weighted-average remaining lease term for operating leases ........................ | 5.4 years | 6.5 years | |
Weighted-average discount rate ........................................................................... | 11.1% | 11.2% |
Year Ended January 31, | Amount | |
2026 .................................................................................................................................................... | $16,562 | |
2027 .................................................................................................................................................... | 12,977 | |
2028 .................................................................................................................................................... | 12,225 | |
2029 .................................................................................................................................................... | 9,306 | |
2030 .................................................................................................................................................... | 7,782 | |
Thereafter ........................................................................................................................................... | 13,428 | |
Total lease payments ....................................................................................................................... | 72,280 | |
Less: imputed interest ...................................................................................................................... | (17,793) | |
Present value of lease payments ................................................................................................... | $54,487 |
Carrying Amount | |
Balance as of January 31, 2023 ...................................................................................................... | $209,305 |
Goodwill arising from acquisitions .............................................................................................. | 6,288 |
Foreign currency translation impact ........................................................................................... | 4,948 |
Balance as of January 31, 2024 ...................................................................................................... | $220,541 |
Goodwill arising from acquisitions .............................................................................................. | 4,006 |
Foreign currency translation impact ........................................................................................... | (4,819) |
Balance as of January 31, 2025 ...................................................................................................... | $219,728 |
As of January 31, 2025 | |||||||
Weighted- Average Remaining Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Amount | ||||
Trade names ..................................................... | 15.2 | $43,579 | $(8,601) | $34,978 | |||
Customer relationships .................................... | 8.6 | 27,989 | (7,921) | 20,068 | |||
Developed technology ..................................... | 0.3 | 507 | (422) | 85 | |||
Domain names .................................................. | 12.8 | 587 | (85) | 502 | |||
Total intangible assets ............................ | $72,662 | $(17,029) | $55,633 |
As of January 31, 2024 | |||||||
Weighted- Average Remaining Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Amount | ||||
Trade names ..................................................... | 16.2 | $44,627 | $(6,516) | $38,111 | |||
Customer relationships .................................... | 9.6 | 27,544 | (5,525) | 22,019 | |||
Developed technology ..................................... | 1.3 | 511 | (170) | 341 | |||
Domain names .................................................. | 13.8 | 587 | (46) | 541 | |||
Total intangible assets ............................ | $73,269 | $(12,257) | $61,012 |
Year Ended January 31, | Amount | |
2026 .................................................................................................................................................... | $4,937 | |
2027 .................................................................................................................................................... | 4,855 | |
2028 .................................................................................................................................................... | 4,643 | |
2029 .................................................................................................................................................... | 4,624 | |
2030 .................................................................................................................................................... | 4,553 | |
Thereafter ........................................................................................................................................... | 32,021 | |
Total ................................................................................................................................................ | $55,633 |
As of January 31, | |||
2025 | 2024 | ||
Convertible notes .................................................................................................... | $125,000 | $125,000 | |
Warehouse credit facility ........................................................................................ | 214,238 | 206,404 | |
Trade loan facility .................................................................................................... | 45,000 | — | |
Notes payable: | |||
2022 promissory note ........................................................................................ | 150,000 | 150,000 | |
Other debt ........................................................................................................... | 968 | 3,439 | |
Total notes payable ................................................................................................ | 150,968 | 153,439 | |
Total principal amount of debt and borrowings .................................................. | 535,206 | 484,843 | |
Less: unamortized debt discount and issuance costs ............................... | (11,324) | (22,039) | |
Plus: accrued interest ...................................................................................... | 94,056 | 60,051 | |
Net carrying value of debt and borrowings ......................................................... | $617,938 | $522,855 |
As of January 31, | |||
2025 | 2024 | ||
Principal .................................................................................................................... | $125,000 | $125,000 | |
Unamortized debt discount .................................................................................... | (7,456) | (13,581) | |
Unamortized debt issuance costs ........................................................................ | (498) | (906) | |
PIK interest added to principal balance ............................................................... | 65,348 | 44,174 | |
Net carrying amount .......................................................................................... | $182,394 | $154,687 |
Year Ended January 31, | |||
2025 | 2024 | ||
Amortization of debt discount ................................................................................ | $6,124 | $9,267 | |
Amortization of debt issuance costs .................................................................... | 409 | 618 | |
PIK interest ............................................................................................................... | 21,174 | 16,155 | |
Total non-cash interest expense ..................................................................... | $27,707 | $26,040 |
As of January 31, | |||
2025 | 2024 | ||
Principal .................................................................................................................... | $150,000 | $150,000 | |
Unamortized debt discount .................................................................................... | (3,342) | (7,488) | |
Unamortized debt issuance costs ........................................................................ | (28) | (64) | |
PIK interest added to principal balance ............................................................... | 28,708 | 15,877 | |
Net carrying amount .......................................................................................... | $175,338 | $158,325 |
Year Ended January 31, | |||
2025 | 2024 | ||
Amortization of debt discount ................................................................................ | $4,147 | $3,295 | |
Amortization of debt issuance costs .................................................................... | 35 | 28 | |
PIK interest ............................................................................................................... | 12,831 | 11,910 | |
Cash interest ............................................................................................................ | 6,843 | 6,335 | |
Total interest expense ...................................................................................... | $23,856 | $21,568 |
Year Ended January 31, | Amount | |
2026 .................................................................................................................................................... | $150,586 | |
2027 .................................................................................................................................................... | 302 | |
2028 .................................................................................................................................................... | 80 | |
2029 .................................................................................................................................................... | — | |
2030 .................................................................................................................................................... | — | |
Thereafter ........................................................................................................................................... | — | |
Total debt outstanding ...................................................................................................................... | $150,968 | |
Less: Unamortized issuance costs and debt discounts .............................................................. | (3,370) | |
Plus: PIK interest ............................................................................................................................... | 28,709 | |
Less: Notes payable, current .......................................................................................................... | (175,913) | |
Notes payable, non-current ............................................................................................................. | $394 |
As of January 31, | |||
2025 | 2024 | ||
Balance Sheet Data of Liquid Labs | |||
Restricted cash, current ......................................................................................... | $57,535 | $30,845 | |
Corporate card receivables(1) ................................................................................ | $158,124 | $192,454 | |
Prepaid expenses and other current assets ....................................................... | $1,001 | $— | |
Other non-current assets ....................................................................................... | $83 | $360 | |
Accrued expenses and other current liabilities held by VIE ............................. | $1,552 | $1,692 | |
Warehouse Credit Facility ..................................................................................... | $214,238 | $206,404 |
Year Ended January 31, | |||
2025 | 2024 | ||
Expected volatility .................................................................................... | 56.09% - 60.19% | 59.13% - 61.13% | |
Risk-free interest rate ............................................................................. | 3.86% - 4.60% | 3.49% - 4.71% | |
Expected term (in years) ........................................................................ | 5.41 - 6.06 | 5.23 - 6.38 | |
Expected dividend yield .......................................................................... | — % | — % |
Number of Stock Options Outstanding | Weighted- Average Exercise Price per Share | Weighted- Average Remaining Contractual Life (Years) | Aggregate Intrinsic Value | ||||
Balance as of January 31, 2024 ............................. | 41,769,970 | $13.90 | 7.8 | $183,079 | |||
Granted ................................................................. | 4,425,665 | $16.85 | |||||
Exercised .............................................................. | (665,863) | $6.80 | $9,104 | ||||
Cancelled/forfeited/expired ................................ | (4,558,675) | $17.36 | |||||
Balance as of January 31, 2025 ............................. | 40,971,097 | $12.80 | 7.0 | $402,471 | |||
Vested and expected to vest as of January 31, 2025 ........................................................................ | 40,971,097 | $12.80 | 7.0 | $402,471 | |||
Exercisable as of January 31, 2025 ....................... | 32,102,738 | $11.74 | 6.5 | $349,174 |
Number of Shares Subject to RSUs | Weighted- Average Grant Date Fair Value | ||
Unvested balance as of January 31, 2024 ......................................................... | 948,938 | $18.69 | |
Granted ............................................................................................................... | 3,777,470 | $20.55 | |
Forfeited .............................................................................................................. | (72,561) | $19.52 | |
Vested ................................................................................................................. | — | $— | |
Unvested balance as of January 31, 2025 ......................................................... | 4,653,847 | $20.19 |
Year Ended January 31, | |||
2025 | 2024 | ||
Cost of revenue ....................................................................................................... | $4,577 | $4,751 | |
Research and development .................................................................................. | 30,408 | 27,039 | |
Sales and marketing ............................................................................................... | 17,077 | 15,872 | |
General and administrative ................................................................................... | 24,919 | 28,189 | |
Total stock-based compensation expense, net of amounts capitalized . | $76,981 | $75,851 | |
Capitalized stock-based compensation ............................................................... | 2,319 | 1,130 | |
Total stock-based compensation cost .......................................................... | $79,300 | $76,981 |
As of January 31, 2025 and 2024 | |||||||||
Shares Authorized | Shares Issued and Outstanding | Original Issuance Price Per Share | Liquidation Amount | Carrying Value | |||||
Series Seed ............................................. | 16,934,856 | 16,934,839 | $0.25 | $4,181 | $4,729 | ||||
Series A ................................................... | 20,382,688 | 20,382,673 | $0.50 | 10,125 | 10,288 | ||||
Series A-1 ................................................ | 21,353,147 | 21,353,143 | $0.59 | 12,500 | 12,670 | ||||
Series B ................................................... | 27,505,170 | 27,465,006 | $1.87 | 51,225 | 51,153 | ||||
Series C ................................................... | 21,158,278 | 19,770,427 | $7.21 | 142,454 | 142,398 | ||||
Series C-1 ................................................ | 1,387,848 | 1,387,848 | $7.21 | 10,000 | 9,996 | ||||
Series D ................................................... | 12,592,724 | 12,592,720 | $22.23 | 279,917 | 279,676 | ||||
Series E ................................................... | 13,859,852 | 13,859,845 | $26.12 | 362,000 | 361,700 | ||||
Series F .................................................... | 8,501,429 | 8,501,424 | $32.35 | 275,000 | 274,827 | ||||
Series G ................................................... | 8,010,956 | 2,670,319 | $37.45 | 100,000 | 99,794 | ||||
Series G-1 ............................................... | 5,340,637 | 1,441,963 | $37.45 | 54,000 | 53,890 | ||||
157,027,585 | 146,360,207 | $1,301,402 | $1,301,121 |
As of January 31, | |||
2025 | 2024 | ||
Redeemable convertible preferred stock ............................................................ | 146,360,207 | 146,360,207 | |
Stock options issued and outstanding ................................................................. | 40,971,097 | 41,769,970 | |
RSUs issued and outstanding ............................................................................... | 4,653,847 | 948,938 | |
Shares of common stock available for future grants ......................................... | 5,486,445 | 4,291,678 | |
Redeemable convertible preferred stock warrants ............................................ | 40,160 | 40,160 | |
Total common stock reserved for issuance ........................................................ | 197,511,756 | 193,410,953 |
Year Ended January 31, | |||
2025 | 2024 | ||
United States ........................................................................................................... | $(206,209) | $(345,485) | |
Foreign ...................................................................................................................... | 34,701 | 19,361 | |
Loss before income tax expense .......................................................................... | $(171,508) | $(326,124) |
Year Ended January 31, | |||
2025 | 2024 | ||
Current: | |||
Federal ................................................................................................................. | $(259) | $(135) | |
State ..................................................................................................................... | 128 | 36 | |
Foreign ................................................................................................................. | 9,700 | 8,751 | |
Total current tax expense ...................................................................................... | 9,569 | 8,652 | |
Deferred: | |||
Federal ................................................................................................................. | — | — | |
State ..................................................................................................................... | 2 | (52) | |
Foreign ................................................................................................................. | (1) | (3,172) | |
Total deferred tax expense (benefit) .................................................................... | 1 | (3,224) | |
Total income tax expense ...................................................................................... | $9,570 | $5,428 |
Year Ended January 31, | |||
2025 | 2024 | ||
Loss before income tax expense .......................................................................... | $(171,508) | $(326,124) | |
Expected tax benefit at federal rate of 21% ........................................................ | (36,017) | (68,486) | |
State taxes ............................................................................................................... | 130 | (16) | |
Taxes on foreign earnings ..................................................................................... | 2,412 | 1,513 | |
Stock-based compensation ................................................................................... | 4,943 | 4,811 | |
Disallowed interest on convertible debt ............................................................... | 3,229 | 11,082 | |
Research and development credits ..................................................................... | (3,912) | (4,102) | |
Effects of cross-border tax laws ........................................................................... | 3,476 | 343 | |
Other ......................................................................................................................... | 1,484 | (147) | |
Change in valuation allowance ............................................................................. | 33,825 | 60,430 | |
Total income tax expense ...................................................................................... | $9,570 | $5,428 |
Year Ended January 31, | |||
2025 | 2024 | ||
Deferred tax assets: | |||
Net operating loss carryforwards ..................................................................... | $211,217 | $209,724 | |
Research and development credits ................................................................. | 18,156 | 14,031 | |
Reserves and accruals ...................................................................................... | 23,841 | 14,378 | |
Depreciation and amortization ......................................................................... | 611 | 674 | |
Capitalized research and development costs ................................................ | 52,012 | 38,764 | |
Operating lease liabilities .................................................................................. | 12,100 | 12,271 | |
Stock-based compensation .............................................................................. | 41,834 | 31,597 | |
Total deferred tax assets ....................................................................................... | 359,771 | 321,439 | |
Less: Valuation allowance ..................................................................................... | (336,627) | (297,643) | |
Net deferred tax assets .......................................................................................... | 23,144 | 23,796 | |
Deferred tax liabilities: | |||
Operating lease right-of-use asset .................................................................. | (10,499) | (11,023) | |
Reserves and accruals ...................................................................................... | (45) | — | |
Depreciation and amortization ......................................................................... | (13,164) | (13,902) | |
Stock-based compensation .............................................................................. | (621) | — | |
Total deferred tax liabilities .................................................................................... | (24,329) | (24,925) | |
Total net deferred tax assets (liabilities) .............................................................. | $(1,185) | $(1,129) |
Year Ended January 31, | |||
2025 | 2024 | ||
Beginning balance .................................................................................................. | $8,783 | $7,477 | |
Additions based on tax position related to the current year ............................. | 1,641 | 1,521 | |
Additions for tax positions for the prior year ....................................................... | 68 | 361 | |
Decrease related to prior year tax positions ....................................................... | (241) | (386) | |
Decrease related to expiration of statute of limitations ..................................... | (794) | (190) | |
Ending balance ........................................................................................................ | $9,457 | $8,783 |
Payments Due By Period as of January 31, 2025 | |||||||||
Total | Less than 1 Year | 1 - 3 Years | 3 - 5 Years | More than 5 Years | |||||
Purchase obligations ....................... | $31,032 | $21,556 | $9,476 | $— | $— |
Year Ended January 31, | |||
2025 | 2024 | ||
Balance at beginning of period(1) .......................................................................... | $5,648 | $5,803 | |
Repayments ........................................................................................................ | (1,118) | (140) | |
Foreign currency translation impact ................................................................ | (215) | (15) | |
Balance at end of period ........................................................................................ | $4,315 | $5,648 | |
Less: balance in Accrued expenses and other current liabilities ................ | (509) | (529) | |
Balance in Other non-current liabilities ........................................................... | $3,806 | $5,119 |
Year Ended January 31, | |||
2025 | 2024 | ||
Net loss ..................................................................................................................... | $(181,078) | $(331,552) | |
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted ............................... | 45,271,666 | 44,583,919 | |
Net loss per share attributable to common stockholders, basic and diluted . | $(4.00) | $(7.44) |
As of January 31, | |||
2025 | 2024 | ||
Redeemable convertible preferred shares .......................................................... | 146,360,207 | 146,360,207 | |
Stock options issued and outstanding ................................................................. | 40,971,097 | 41,769,970 | |
RSUs issued and outstanding ............................................................................... | 4,653,847 | 948,938 | |
Warrants to purchase redeemable convertible preferred stock ...................... | 40,160 | 40,160 | |
Shares of common stock subject to repurchase ................................................ | 49,761 | 133,332 | |
Convertible notes .................................................................................................... | 12,946,170 | 13,980,833 | |
Total antidilutive securities .................................................................................... | 205,021,242 | 203,233,440 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents .............................................................................. | $223,229 | $157,672 | |
Restricted cash, current .................................................................................... | 87,218 | 148,157 | |
Accounts receivable, net ................................................................................... | 191,080 | 184,856 | |
Corporate card receivables, net ....................................................................... | 158,421 | 157,755 | |
Contract acquisition costs, current .................................................................. | 6,586 | 4,784 | |
Prepaid expenses and other current assets .................................................. | 52,353 | 35,628 | |
Total current assets ................................................................................................ | 718,887 | 688,852 | |
Restricted cash, non-current ................................................................................. | 5,091 | 4,766 | |
Contract acquisition costs, non-current ............................................................... | 21,089 | 16,185 | |
Operating lease right-of-use assets ..................................................................... | 44,364 | 48,006 | |
Property, equipment, and software, net .............................................................. | 30,092 | 29,538 | |
Intangible assets, net ............................................................................................. | 56,346 | 55,633 | |
Goodwill .................................................................................................................... | 234,656 | 219,728 | |
Other non-current assets ....................................................................................... | 23,866 | 21,246 | |
Total assets .............................................................................................................. | $1,134,391 | $1,083,954 | |
Liabilities, redeemable convertible preferred stock and stockholders’ deficit | |||
Current liabilities: | |||
Accounts payable ............................................................................................... | $48,209 | $42,829 | |
Accrued expenses and other current liabilities .............................................. | 148,787 | 136,798 | |
Notes payable, current ...................................................................................... | 1,602 | 175,913 | |
Trade loan facility ............................................................................................... | — | 45,000 | |
Operating lease liabilities, current ................................................................... | 11,056 | 11,389 | |
Deferred revenue, current ..................................................................................... | 39,589 | 34,097 | |
Total current liabilities ............................................................................................. | 249,243 | 446,026 | |
Operating lease liabilities, non-current ................................................................ | 39,718 | 43,098 | |
Convertible notes and SAFEs ............................................................................... | 358,163 | 182,394 | |
Embedded derivative and common stock warrant liabilities ............................ | 69,700 | 59,820 | |
ABL facility ............................................................................................................... | 34,500 | — | |
Warehouse credit facility ........................................................................................ | 148,174 | 214,238 | |
Notes payable, non-current ................................................................................... | 117,321 | 394 | |
Deferred revenue, non-current ............................................................................. | 1,224 | 813 | |
Other non-current liabilities ................................................................................... | 23,678 | 22,949 | |
Total liabilities .......................................................................................................... | 1,041,721 | 969,732 | |
Commitments and contingencies (Note 12) | |||
Redeemable convertible preferred stock, par value $0.00000625; 157,027,585 shares authorized; 146,360,207 issued and outstanding (aggregate liquidation preference of $1,301,402) .......................................... | 1,301,121 | 1,301,121 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Stockholders’ deficit | |||
Common stock, par value $0.00000625 per share; 253,919,000 shares authorized, 46,331,272 and 45,782,871 shares issued and outstanding as of July 31, 2025 and January 31, 2025, respectively ............................... | 1 | 1 | |
Additional paid-in capital ................................................................................... | 522,555 | 467,835 | |
Accumulated deficit ............................................................................................ | (1,716,993) | (1,617,113) | |
Accumulated other comprehensive loss ......................................................... | (14,014) | (37,622) | |
Total stockholders’ deficit ...................................................................................... | (1,208,451) | (1,186,899) | |
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit ..................................................................................................................... | $1,134,391 | $1,083,954 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Revenue ................................................................................................................... | $329,413 | $253,727 | |
Cost of revenue ....................................................................................................... | 92,583 | 82,545 | |
Gross profit ............................................................................................................... | 236,830 | 171,182 | |
Operating expenses | |||
Research and development ............................................................................. | 64,760 | 57,784 | |
Sales and marketing .......................................................................................... | 130,376 | 103,530 | |
General and administrative ............................................................................... | 69,845 | 65,238 | |
Total operating expenses ...................................................................................... | 264,981 | 226,552 | |
Loss from operations .............................................................................................. | (28,151) | (55,370) | |
Interest expense ................................................................................................. | (31,971) | (37,851) | |
Other income, net ............................................................................................... | 6,699 | 1,953 | |
Loss on extinguishment of debt ....................................................................... | (20,528) | — | |
Gain (loss) on fair value adjustments ............................................................. | (17,886) | 3,020 | |
Loss before income tax expense .......................................................................... | (91,837) | (88,248) | |
Income tax expense ............................................................................................... | 8,043 | 4,296 | |
Net loss ..................................................................................................................... | $(99,880) | $(92,544) | |
Net loss per share attributable to common stockholders: | |||
Basic and diluted net loss per share .................................................................... | $(2.15) | $(2.05) | |
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders ............................................................... | 46,350,553 | 45,153,649 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Net loss ..................................................................................................................... | $(99,880) | $(92,544) | |
Other comprehensive income, net of tax: | |||
Foreign currency translation adjustments ........................................................... | 23,608 | 2,944 | |
Total other comprehensive income, net of tax ................................................... | 23,608 | 2,944 | |
Total comprehensive loss ...................................................................................... | $(76,272) | $(89,600) |
Accumulated | ||||||||||||||||
Redeemable Convertible Preferred Stock | Common Stock | Additional paid- in | Accumulated | other comprehensive | Total stockholders' | |||||||||||
Shares | Amount | Shares | Amount | capital | deficit | income (loss) | deficit | |||||||||
Balance as of January 31, 2025 .............................. | 146,360,207 | $1,301,121 | 45,782,871 | $1 | $467,835 | $(1,617,113) | $(37,622) | $(1,186,899) | ||||||||
Net loss ..................................................................... | — | — | — | — | — | (99,880) | — | (99,880) | ||||||||
Other comprehensive income, net of tax ............. | — | — | — | — | — | — | 23,608 | 23,608 | ||||||||
Issuance of common stock warrants .................... | — | — | — | — | 11,007 | — | — | 11,007 | ||||||||
Issuance of common stock upon exercise of stock options ............................................................. | — | — | 548,401 | — | 5,826 | — | — | 5,826 | ||||||||
Vesting of early exercised stock options .............. | — | — | — | — | 583 | — | — | 583 | ||||||||
Stock-based compensation .................................... | — | — | — | — | 37,304 | — | — | 37,304 | ||||||||
Balance as of July 31, 2025 ...................................... | 146,360,207 | $1,301,121 | 46,331,272 | $1 | $522,555 | $(1,716,993) | $(14,014) | $(1,208,451) |
Accumulated | ||||||||||||||||
Redeemable Convertible Preferred Stock | Common Stock | Additional paid- in | Accumulated | other comprehensive | Total stockholders' | |||||||||||
Shares | Amount | Shares | Amount | capital | deficit | income (loss) | deficit | |||||||||
Balance as of January 31, 2024 .............................. | 146,360,207 | $1,301,121 | 45,117,008 | $1 | $382,356 | $(1,436,035) | $(28,293) | $(1,081,971) | ||||||||
Net loss ..................................................................... | — | — | — | — | — | (92,544) | — | (92,544) | ||||||||
Other comprehensive income, net of tax ............. | — | — | — | — | — | — | 2,944 | 2,944 | ||||||||
Issuance of common stock upon exercise of stock options ............................................................. | — | — | 239,300 | — | 1,980 | — | — | 1,980 | ||||||||
Vesting of early exercised stock options .............. | — | — | — | — | 1,064 | — | — | 1,064 | ||||||||
Stock-based compensation .................................... | — | — | — | — | 36,009 | — | — | 36,009 | ||||||||
Balance as of July 31, 2024 ...................................... | 146,360,207 | $1,301,121 | 45,356,308 | $1 | $421,409 | $(1,528,579) | $(25,349) | $(1,132,518) |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Cash flows from operating activities: | |||
Net loss ................................................................................................................ | $(99,880) | $(92,544) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||
Stock-based compensation, net of amounts capitalized ......................... | 35,909 | 34,913 | |
Non-cash interest expense .......................................................................... | 17,634 | 24,052 | |
Deferred income taxes ................................................................................. | 350 | (371) | |
Depreciation and amortization .................................................................... | 12,209 | 12,827 | |
Amortization of contract acquisition costs ................................................. | 2,541 | 2,716 | |
Provision for doubtful accounts ................................................................... | 4,385 | 2,908 | |
Loss (gain) on fair value adjustments ........................................................ | 17,886 | (3,020) | |
Debt issuance costs expensed related to SAFEs .................................... | 2,913 | — | |
Loss on extinguishment of debt .................................................................. | 20,528 | — | |
Other ................................................................................................................ | (327) | 22 | |
Changes in operating assets and liabilities, net of effect of business acquisitions: | |||
Accounts receivable ................................................................................. | (1,518) | (429) | |
Prepaid expenses and other current assets ......................................... | (14,927) | (10,201) | |
Contract acquisition costs ....................................................................... | (9,247) | (10,713) | |
Other non-current assets ......................................................................... | 858 | 12 | |
Accounts payable ..................................................................................... | 2,933 | 20,497 | |
Accrued expenses and other current liabilities .................................... | 6,844 | (15,807) | |
Deferred revenue ...................................................................................... | 5,858 | 3,600 | |
Operating lease right-of-use asset and operating lease liabilities, net ............................................................................................................... | (96) | 2,503 | |
Other non-current liabilities ..................................................................... | (69) | 2 | |
Net cash provided by (used in) operating activities ........................ | 4,784 | (29,033) | |
Cash flows from investing activities: | |||
Capitalized software development costs ................................................... | (8,207) | (7,867) | |
Purchases of property and equipment ....................................................... | (188) | (574) | |
Proceeds from sale of subsidiary, net of cash sold ................................. | (354) | — | |
Decrease (increase) in corporate card receivables ................................. | (2,306) | 38,392 | |
Cash consideration for business acquisition, net of cash acquired ...... | — | (3,879) | |
Net cash provided by (used in) investing activities ........................ | (11,055) | 26,072 | |
Cash flows from financing activities: | |||
Proceeds from issuance of common stock from exercise of stock- based awards ................................................................................................. | 6,154 | 2,277 | |
Proceeds from borrowings of debt .............................................................. | 190,967 | 51,718 | |
Proceeds from issuance of SAFEs ............................................................. | 155,000 | — | |
Payments of borrowings of debt ................................................................. | (333,775) | (2,270) | |
Payments for debt issuance costs .............................................................. | (10,985) | (35) | |
Payments of deferred offering costs .......................................................... | (755) | — | |
Payment of deferred consideration in business combinations ............... | — | (275) |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Net cash provided by financing activities ......................................... | 6,606 | 51,415 | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash ...................................................................................... | 4,608 | (499) | |
Net increase in cash, cash equivalents and restricted cash ......... | 4,943 | 47,955 | |
Cash, cash equivalents and restricted cash, beginning of period ................... | $310,595 | $267,382 | |
Cash, cash equivalents and restricted cash, end of period ............................. | $315,538 | $315,337 | |
Supplemental disclosure of cash flow information: | |||
Cash paid for interest .................................................................................... | $14,337 | $13,799 | |
Cash paid for income taxes ......................................................................... | $9,386 | $4,115 | |
Noncash investing and financing activities: | |||
Vesting of early exercised stock options ................................................... | $583 | $1,064 | |
Capitalized share-based compensation for internal-use software development costs ........................................................................................ | $1,395 | $1,096 | |
Amounts unpaid for purchases of property and equipment .................... | $8 | $606 | |
Deferred offering costs not yet paid ........................................................... | $2,600 | $— |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Usage-based revenue ............................................................................................ | $299,698 | $232,448 | |
Subscription revenue .............................................................................................. | 29,715 | 21,279 | |
Total revenue ...................................................................................................... | $329,413 | $253,727 |
Six Months Ended July 31, | |||||||
2025 | 2024 | ||||||
Amount | Percentage of Revenue | Amount | Percentage of Revenue | ||||
United States ..................................................... | $201,318 | 61% | $147,676 | 59% | |||
United Kingdom ................................................ | 71,549 | 22% | 64,518 | 25% | |||
Rest of World(1) ................................................. | 56,546 | 17% | 41,533 | 16% | |||
Total revenue ............................................... | $329,413 | 100% | $253,727 | 100% |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Balance at beginning of period ........................................................................ | $5,135 | $4,270 | |
Provision for expected credit losses ............................................................... | 2,488 | 1,677 | |
Amounts written off, recoveries and other adjustments ............................... | (1,739) | (1,161) | |
Balance at end of period .................................................................................... | $5,884 | $4,786 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Balance at beginning of period ........................................................................ | $380 | $566 | |
Provision for expected credit losses ............................................................... | 1,675 | 1,275 | |
Amounts written off, recoveries and other adjustments ............................... | (1,045) | 426 | |
Balance at end of period .................................................................................... | $1,010 | $2,267 |
Fair value measurements as of July 31, 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
Financial Liabilities | |||||||
Redeemable convertible preferred stock warrant liability ............................................... | $— | $— | $433 | $433 | |||
Embedded derivative liability ......................... | — | — | 38,500 | 38,500 | |||
SAFE liability ..................................................... | — | — | 163,000 | 163,000 | |||
Common stock warrant liability ...................... | — | — | 31,200 | 31,200 | |||
Total ............................................................... | $— | $— | $233,133 | $233,133 |
Fair value measurements as of January 31, 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
Financial Liabilities | |||||||
Redeemable convertible preferred stock warrant liability ................................................ | — | — | 427 | 427 | |||
Embedded derivative liability .......................... | — | — | 59,820 | 59,820 | |||
Total ................................................................ | $— | $— | $60,247 | $60,247 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Volatility .................................................................................................................... | 50.0% | 55.0% | |
Risk-free interest rate ............................................................................................. | 3.9% | 4.1% | |
Expected term (in years) ........................................................................................ | 3.1 | 3.9 | |
Dividend yield .......................................................................................................... | —% | —% |
Balance as of January 31, 2025 ...................................................................................................... | $427 |
Change in fair value ........................................................................................................................... | 6 |
Balance as of July 31, 2025 ............................................................................................................. | $433 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Time to expiration (in years) .......................................................................... | 0.21 - 1.21 | 0.70 - 1.70 | |
Time from conversion to maturity (in years) ............................................... | 0.65 - 1.65 | 0.65 - 1.65 | |
Discount factor ................................................................................................. | 9.0% | 9.0% | |
Volatility ............................................................................................................. | 48.6 - 74.5% | 57.8% - 72.6% | |
Risk free rate .................................................................................................... | 3.99 - 4.33% | 4.1% - 4.2% |
Balance as of January 31, 2025 ...................................................................................................... | $59,820 |
Change in fair value ........................................................................................................................... | (21,320) |
Balance as of July 31, 2025 ............................................................................................................. | $38,500 |
Balance as of January 31, 2025 ...................................................................................................... | $— |
Additions in the period .................................................................................................................. | 127,300 |
Change in fair value ...................................................................................................................... | 35,700 |
Balance as of July 31, 2025 ............................................................................................................. | $163,000 |
As of | |
July 31, 2025 | |
Time until conversion (in years) ....................................................................................................... | 0.21 - 1.21 |
Discount for lack of marketability ..................................................................................................... | 5.0 - 18.0% |
Balance as of January 31, 2025 ...................................................................................................... | $— |
Additions in the period .................................................................................................................. | 27,700 |
Change in fair value ...................................................................................................................... | 3,500 |
Balance as of July 31, 2025 ............................................................................................................. | $31,200 |
Fair Value Hierarchy | As of | ||||
July 31, 2025 | January 31, 2025 | ||||
Convertible notes ......................................................................... | Level 3 | $354,000 | $359,200 | ||
Warehouse credit facility ............................................................ | Level 3 | $140,864 | $210,995 | ||
ABL facility .................................................................................... | Level 3 | $34,386 | $— | ||
Vista facility ................................................................................... | Level 3 | $129,725 | $— | ||
Trade loan facility ......................................................................... | Level 3 | — | $45,000 | ||
2022 promissory note ................................................................. | Level 3 | — | $179,932 | ||
Other debt ..................................................................................... | Level 3 | $1,810 | $933 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Capitalized software ............................................................................................... | $44,479 | $42,317 | |
Computers and equipment .................................................................................... | 7,622 | 7,349 | |
Fixtures and fittings ................................................................................................. | 3,568 | 3,561 | |
Leasehold improvements ....................................................................................... | 2,840 | 2,779 | |
Construction in progress(1) ..................................................................................... | 2,919 | 2,960 | |
Property, equipment and software, gross ...................................................... | 61,428 | 58,966 | |
Less: accumulated depreciation ........................................................................... | (31,336) | (29,428) | |
Property, equipment and software, net ........................................................... | $30,092 | $29,538 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
United States ........................................................................................................... | $56,792 | $59,181 | |
United Kingdom ....................................................................................................... | 10,684 | 10,633 | |
All other countries ................................................................................................... | 6,980 | 7,730 | |
Total long-lived assets, net ............................................................................... | $74,456 | $77,544 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Prepaid expenses ................................................................................................... | $20,108 | $16,965 | |
Payment processor advances(1) .......................................................................... | 12,274 | 6,801 | |
Tax receivable ......................................................................................................... | 2,671 | 3,196 | |
Deferred offering costs ........................................................................................... | 3,355 | — | |
Other current assets ............................................................................................... | 13,945 | 8,666 | |
Total prepaid expenses and other current assets | $52,353 | $35,628 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Accrued compensation and employee benefits ................................................. | $31,924 | $28,970 | |
Accrued expenses .................................................................................................. | 33,362 | 27,354 | |
Amounts due to travel supply partners(1) ........................................................... | 40,906 | 41,665 | |
Reward liability(2) ................................................................................................... | 11,802 | 11,408 | |
Customer deposits and collateral ......................................................................... | 18,140 | 14,319 | |
Corporate tax payable ............................................................................................ | 2,311 | 4,640 | |
Indirect tax payable ................................................................................................. | 4,503 | 3,489 | |
Early exercise liability ............................................................................................. | 421 | 976 | |
Accrued interest ...................................................................................................... | 3,688 | 2,642 | |
Other ......................................................................................................................... | 1,730 | 1,335 | |
Total accrued expenses and other current liabilities .................................... | $148,787 | $136,798 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Loss contingency reserves(1) ................................................................................. | $7,618 | $8,120 | |
Deferred tax liability ................................................................................................ | 8,126 | 7,655 | |
Taxes payable for unrecognized tax benefits ..................................................... | 2,573 | 2,288 | |
Redeemable convertible preferred stock warrant liability ................................. | 433 | 427 | |
NOW Scheme contingency payable(2) ................................................................. | 4,192 | 3,806 | |
Other non-current liabilities ................................................................................... | 736 | 653 | |
Total other non-current liabilities ..................................................................... | $23,678 | $22,949 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Foreign currency exchange gains (losses), net ................................................. | $7,622 | $(651) | |
Interest income ........................................................................................................ | 2,203 | 2,523 | |
SAFE issuance costs expensed ........................................................................... | (2,913) | — | |
Other, net ................................................................................................................. | (213) | 81 | |
Total other income, net | $6,699 | $1,953 |
Carrying Amount | |
Balance as of January 31, 2025 ...................................................................................................... | $219,728 |
Goodwill arising from acquisitions .............................................................................................. | — |
Foreign currency translation impact ........................................................................................... | 14,928 |
Balance as of July 31, 2025 ............................................................................................................. | $234,656 |
As of July 31, 2025 | |||||||
Weighted- Average Remaining Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Amount | ||||
Trade names ..................................................... | 14.7 | $46,540 | $(10,410) | $36,130 | |||
Customer relationships .................................... | 8.2 | 29,353 | (9,620) | 19,733 | |||
Domain names .................................................. | 12.3 | $587 | $(104) | 483 | |||
Total intangible assets ............................... | $76,480 | $(20,134) | $56,346 |
As of January 31, 2025 | |||||||
Weighted- Average Remaining Life (Years) | Gross Carrying Amount | Accumulated Amortization | Net Amount | ||||
Trade names ...................................................... | 15.2 | $43,579 | $(8,601) | $34,978 | |||
Customer relationships ..................................... | 8.6 | 27,989 | (7,921) | 20,068 | |||
Developed technology ...................................... | 0.3 | 507 | (422) | 85 | |||
Domain names ................................................... | 12.8 | 587 | (85) | 502 | |||
Total intangible assets ................................ | $72,662 | $(17,029) | $55,633 |
Year Ended January 31, | Amount |
Remainder of 2026 ............................................................................................................................ | $2,560 |
2027 ...................................................................................................................................................... | 5,121 |
2028 ...................................................................................................................................................... | 4,920 |
2029 ...................................................................................................................................................... | 4,902 |
2030 ...................................................................................................................................................... | 4,825 |
Thereafter ............................................................................................................................................ | 34,018 |
Total ................................................................................................................................................. | $56,346 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Convertible notes .................................................................................................... | $125,000 | $125,000 | |
SAFEs ....................................................................................................................... | 163,000 | — | |
Warehouse credit facility ........................................................................................ | 148,174 | 214,238 | |
Trade loan facility .................................................................................................... | — | 45,000 | |
ABL facility ............................................................................................................... | 34,500 | — | |
Notes payable: | |||
2022 promissory note ........................................................................................ | — | 150,000 | |
Vista facility ......................................................................................................... | 130,000 | — | |
Other debt ........................................................................................................... | 1,823 | 968 | |
Total notes payable ................................................................................................ | 131,823 | 150,968 | |
Total principal amount of debt and borrowings .................................................. | 602,497 | 535,206 | |
Less: unamortized debt discount and issuance costs ............................. | (20,834) | (11,324) | |
Plus: accrued interest ................................................................................... | 78,097 | 94,056 | |
Net carrying value of debt and borrowings ......................................................... | $659,760 | $617,938 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Principal .................................................................................................................... | $125,000 | $125,000 | |
Unamortized debt discount .................................................................................... | (6,638) | (7,456) | |
Unamortized debt issuance costs ........................................................................ | (443) | (498) | |
PIK interest added to principal balance ............................................................... | 77,244 | 65,348 | |
Net carrying amount .......................................................................................... | $195,163 | $182,394 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Amortization of debt discount ................................................................................ | $818 | $4,608 | |
Amortization of debt issuance costs .................................................................... | 55 | 308 | |
PIK interest ............................................................................................................... | 11,897 | 9,977 | |
Total non-cash interest expense ..................................................................... | $12,770 | $14,893 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Principal .................................................................................................................... | $130,000 | $— | |
Unamortized debt discount .................................................................................... | (10,336) | — | |
Unamortized debt issuance costs ........................................................................ | (3,417) | — | |
PIK interest added to principal balance ............................................................... | 853 | — | |
Net carrying amount .......................................................................................... | $117,100 | $— |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Amortization of debt discount ................................................................................ | $671 | — | |
Amortization of debt issuance costs .................................................................... | 222 | — | |
PIK interest ............................................................................................................... | 853 | — | |
Cash interest ............................................................................................................ | 5,303 | — | |
Total interest expense ....................................................................................... | $7,049 | $— |
Fiscal Year | Amount | |
Remainder of 2026 ........................................................................................................................... | $1,425 | |
2027 .................................................................................................................................................... | 332 | |
2028 .................................................................................................................................................... | 66 | |
2029 .................................................................................................................................................... | — | |
2030 .................................................................................................................................................... | 130,000 | |
Thereafter ........................................................................................................................................... | — | |
Total debt outstanding ...................................................................................................................... | $131,823 | |
Less: Unamortized issuance costs and debt discounts .............................................................. | (13,753) | |
Plus: PIK interest ............................................................................................................................... | 853 | |
Less: Notes payable, current .......................................................................................................... | (1,602) | |
Notes payable, non-current ............................................................................................................. | $117,321 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Amortization of debt discount ................................................................................ | $298 | $1,914 | |
Amortization of debt issuance costs .................................................................... | 3 | 16 | |
PIK interest ............................................................................................................... | 839 | 6,261 | |
Cash interest ............................................................................................................ | 448 | 3,340 | |
Total interest expense ....................................................................................... | $1,588 | $11,531 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Balance Sheet Data of Liquid Labs | |||
Restricted cash, current ......................................................................................... | $12,706 | $57,535 | |
Corporate card receivables(1) ................................................................................ | $159,408 | $158,124 | |
Prepaid expenses and other current assets ....................................................... | $1,281 | $1,001 | |
Other non-current assets ....................................................................................... | $2,029 | $83 | |
Accrued expenses and other current liabilities .................................................. | $1,140 | $1,552 | |
Warehouse Credit Facility ..................................................................................... | $148,174 | $214,238 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Expected volatility ................................................................................. | 56.76% - 58.49% | 58.93% - 60.19% | |
Risk-free interest rate ........................................................................... | 3.93% - 4.07% | 4.33% - 4.60% | |
Expected term (in years) ...................................................................... | 5.23 - 6.07 | 5.41 - 6.06 | |
Expected dividend yield ....................................................................... | —% | —% |
Number of Stock Options Outstanding | Weighted- Average Exercise Price per Share | Weighted- Average Remaining Contractual Life (Years) | Aggregate Intrinsic Value | ||||
Balance as of January 31, 2025 ..................... | 40,971,097 | $12.80 | 7.0 | $402,471 | |||
Granted .......................................................... | 2,574,917 | $22.66 | |||||
Exercised ....................................................... | (548,401) | $10.67 | $7,412 | ||||
Cancelled/forfeited/expired ......................... | (1,415,880) | $16.29 | |||||
Balance as of July 31, 2025 ............................ | 41,581,733 | $13.32 | 6.6 | $500,356 | |||
Vested and expected to vest as of July 31, 2025 ................................................................. | 41,581,733 | $13.32 | 6.6 | $500,356 | |||
Exercisable as of July 31, 2025 ...................... | 33,247,634 | $11.99 | 6.1 | $444,352 |
Number of Shares Subject to RSUs | Weighted- Average Grant Date Fair Value | ||
Unvested balance as of January 31, 2025 ......................................................... | 4,551,847 | $20.50 | |
Granted ................................................................................................................ | 2,744,173 | $23.30 | |
Forfeited ............................................................................................................... | (153,371) | $21.46 | |
Vested .................................................................................................................. | — | — | |
Unvested balance as of July 31, 2025 ................................................................ | 7,142,649 | $21.32 |
Number of Shares Subject to RSUs | Weighted- Average Grant Date Fair Value | ||
Unvested balance as of January 31, 2025 ......................................................... | 102,000 | $22.38 | |
Granted ................................................................................................................ | 527,117 | $23.28 | |
Forfeited ............................................................................................................... | — | — | |
Vested .................................................................................................................. | — | — | |
Unvested balance as of July 31, 2025 ................................................................ | 629,117 | $23.14 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Cost of revenue ....................................................................................................... | $1,902 | $1,842 | |
Research and development .................................................................................. | 14,371 | 13,619 | |
Sales and marketing ............................................................................................... | 7,738 | 7,614 | |
General and administrative ................................................................................... | 11,898 | 11,838 | |
Total stock-based compensation expense, net of amounts capitalized .... | $35,909 | $34,913 | |
Capitalized stock-based compensation ............................................................... | 1,395 | 1,096 | |
Total stock-based compensation cost ............................................................ | $37,304 | $36,009 |
As of July 31, 2025 and January 31, 2025 | |||||||||
Shares Authorized | Shares Issued and Outstanding | Original Issuance Price Per Share | Liquidation Amount | Carrying Value | |||||
Series Seed ............................ | 16,934,856 | 16,934,839 | $0.25 | $4,181 | $4,729 | ||||
Series A .................................. | 20,382,688 | 20,382,673 | $0.50 | 10,125 | 10,288 | ||||
Series A-1 ............................... | 21,353,147 | 21,353,143 | $0.59 | 12,500 | 12,670 | ||||
Series B .................................. | 27,505,170 | 27,465,006 | $1.87 | 51,225 | 51,153 | ||||
Series C .................................. | 21,158,278 | 19,770,427 | $7.21 | 142,454 | 142,398 | ||||
Series C-1 .............................. | 1,387,848 | 1,387,848 | $7.21 | 10,000 | 9,996 | ||||
Series D .................................. | 12,592,724 | 12,592,720 | $22.23 | 279,917 | 279,676 | ||||
Series E .................................. | 13,859,852 | 13,859,845 | $26.12 | 362,000 | 361,700 | ||||
Series F .................................. | 8,501,429 | 8,501,424 | $32.35 | 275,000 | 274,827 | ||||
Series G .................................. | 8,010,956 | 2,670,319 | $37.45 | 100,000 | 99,794 | ||||
Series G-1 .............................. | 5,340,637 | 1,441,963 | $37.45 | 54,000 | 53,890 | ||||
157,027,585 | 146,360,207 | $1,301,402 | $1,301,121 |
As of | |||
July 31, 2025 | January 31, 2025 | ||
Redeemable convertible preferred stock ......................................................... | 146,360,207 | 146,360,207 | |
Stock options issued and outstanding ............................................................. | 41,581,733 | 40,971,097 | |
RSUs issued and outstanding ........................................................................... | 7,771,766 | 4,653,847 | |
Shares of common stock available for future grants ..................................... | 5,876,145 | 5,486,445 | |
Redeemable convertible preferred stock warrants ........................................ | 40,160 | 40,160 | |
Common stock warrants .................................................................................... | 1,697,811 | — | |
Total common stock reserved for issuance .................................................... | 203,327,822 | 197,511,756 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Income Tax Provision ............................................................................................. | $8,043 | $4,296 | |
Effective Tax Rate ................................................................................................... | (8.8)% | (4.9)% |
Payments Due By Period as of July 31, 2025 | |||||||||
Total | Less than 1 Year | 1 - 3 Years | 3 - 5 Years | More than 5 Years | |||||
Purchase obligations ............ | $40,811 | $17,656 | $19,055 | $4,100 | $— |
Carrying Amount | |
Balance as of January 31, 2025 ...................................................................................................... | $4,315 |
Repayments ................................................................................................................................... | — |
Foreign currency translation impact ........................................................................................... | 437 |
Balance as of July 31, 2025 ............................................................................................................. | $4,752 |
Less: balance in accrued expenses and other current liabilities ........................................... | (560) |
Balance in other non-current liabilities ............................................................................................ | $4,192 |
Six Months Ended July 31, | |||
2025 | 2024 | ||
Net loss ..................................................................................................................... | $(99,880) | $(92,544) | |
Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted ............................... | 46,350,553 | 45,153,649 | |
Net loss per share attributable to common stockholders, basic and diluted . | $(2.15) | $(2.05) |
As of July 31, | |||
2025 | 2024 | ||
Redeemable convertible preferred shares .......................................................... | 146,360,207 | 146,360,207 | |
Stock options issued and outstanding ................................................................. | 41,581,733 | 42,009,551 | |
RSUs issued and outstanding ............................................................................... | 7,771,766 | 2,718,566 | |
Warrants to purchase redeemable convertible preferred stock ...................... | 40,160 | 40,160 | |
Warrants to purchase common stock .................................................................. | 1,211,223 | — | |
Shares of common stock subject to repurchase ................................................ | 21,751 | 79,293 | |
Convertible notes .................................................................................................... | 12,273,965 | 16,322,776 | |
SAFEs ....................................................................................................................... | 7,526,948 | — | |
Total antidilutive securities .................................................................................... | 216,787,753 | 207,530,553 |
Amount Paid or to be Paid | ||
SEC registration fee ....................................................................................................................... | $ | * |
FINRA filing fee ............................................................................................................................... | * | |
Listing fee ........................................................................................................................................ | * | |
Printing and engraving expenses ................................................................................................ | * | |
Legal fees and expenses .............................................................................................................. | * | |
Accounting fees and expenses .................................................................................................... | * | |
Transfer agent and registrar fees and expenses ...................................................................... | * | |
Miscellaneous expenses ............................................................................................................... | * | |
Total .................................................................................................................................................. | $ | * |
Exhibit Number | Description of Document | |
1.1* | Form of Underwriting Agreement. | |
3.1 | ||
3.2* | Form of Amended and Restated Certificate of Incorporation of Navan, Inc., to be in effect upon the completion of this offering. | |
3.3 | ||
3.4* | Form of Amended and Restated Bylaws of Navan, Inc., to be in effect upon the completion of this offering. | |
4.1* | Form of Class A Common Stock certificate of Navan, Inc. | |
4.2 | ||
4.3 | ||
5.1* | Opinion of Cooley LLP. | |
10.1 | ||
10.2+ | ||
10.3+* | Navan, Inc. 2025 Equity Incentive Plan and related form agreements. | |
10.4+* | Navan, Inc. 2025 Employee Stock Purchase Plan and related form agreements. | |
10.5+* | Confirmatory Offer Letter between Ariel Cohen and Navan, Inc., dated . | |
10.6+* | Confirmatory Offer Letter between Michael Sindicich and Navan, Inc., dated . |
10.7+* | Confirmatory Offer Letter between Ilan Twig and Navan, Inc., dated . | |
10.8* | Form of Change of Control and Severance Agreement between Navan, Inc. and each of its named executive officers. | |
10.9 | ||
10.10†^ | ||
10.11† | ||
10.12†^ | ||
10.13* | Form of Exchange Agreement between Navan, Inc., Ariel Cohen, and Ilan Twig. | |
10.14* | Form of Equity Exchange Right Agreement between Navan, Inc. and each of Ariel Cohen and Ilan Twig. | |
16.1 | ||
21.1* | List of Subsidiaries of Navan, Inc. | |
23.1 | ||
23.2* | Consent of Cooley LLP (included in Exhibit 5.1). | |
23.3 | ||
24.1 | ||
107 |
NAVAN, INC. | ||
By: | /s/ Ariel Cohen | |
Ariel Cohen | ||
Chairperson of the Board of Directors and Chief Executive Officer |
Signature | Title | Date | ||
/s/ Ariel Cohen | Chairperson of the Board of Directors and Chief Executive Officer (Principal Executive Officer) | September 19, 2025 | ||
Ariel Cohen | ||||
/s/ Amy Butte | Chief Financial Officer (Principal Financial Officer) | September 19, 2025 | ||
Amy Butte | ||||
/s/ Anne Giviskos | Chief Accounting Officer (Principal Accounting Officer) | September 19, 2025 | ||
Anne Giviskos | ||||
/s/ Ben Horowitz | Director | September 19, 2025 | ||
Ben Horowitz | ||||
/s/ Arif Janmohamed | Director | September 19, 2025 | ||
Arif Janmohamed | ||||
/s/ Michael Kourey | Director | September 19, 2025 | ||
Michael Kourey | ||||
/s/ Clara Liang | Director | September 19, 2025 | ||
Clara Liang | ||||
/s/ Sandesh Patnam | Director | September 19, 2025 | ||
Sandesh Patnam | ||||
/s/ Ilan Twig | Chief Technology Officer and Director | September 19, 2025 | ||
Ilan Twig | ||||
/s/ Anré Williams | Director | September 19, 2025 | ||
Anré Williams | ||||
/s/ Oren Zeev | Director | September 19, 2025 | ||
Oren Zeev |